EXHIBIT 4.10
EXECUTION VERSION
AMENDED AND RESTATED
SERIES B PREFERRED SHARE PURCHASE AGREEMENT
dated as of December 15, 2006
by and among
YINGLI GREEN ENERGY HOLDING COMPANY LIMITED,
YINGLI POWER HOLDING COMPANY LTD.,
▇▇▇▇▇▇▇▇▇ ▇▇▇▇,
and
THE INVESTORS
LISTED ON SCHEDULE I ATTACHED HERETO
TABLE OF CONTENTS
Page No.
--------
ARTICLE I SALE OF SHARES AND CLOSING................................. 1
SECTION 1.01. Purchase and Sale.................................. 1
SECTION 1.02. Closing............................................ 2
SECTION 1.03. Purchase Price..................................... 2
SECTION 1.04. Share Certificate.................................. 2
SECTION 1.05. Use of Proceeds.................................... 3
SECTION 1.06. Escrow Arrangement................................. 4
SECTION 1.07. Further Assurances................................. 5
ARTICLE II REPRESENTATIONS AND WARRANTIES OF THE COMPANY............. 6
SECTION 2.01. Power and Authority................................ 6
SECTION 2.02. Execution and Delivery............................. 6
SECTION 2.03. Corporate Existence of the Company................. 6
SECTION 2.04. Company Capital Stock.............................. 6
SECTION 2.05. Subsidiaries....................................... 7
SECTION 2.06. No Conflicts....................................... 8
SECTION 2.07. Governmental Approvals and Filings................. 9
SECTION 2.08. Books and Records.................................. 9
SECTION 2.09. Financial Statements and Condition................. 9
SECTION 2.10. Taxes.............................................. 10
SECTION 2.11. Legal Proceedings.................................. 10
SECTION 2.12. Compliance With Laws and Orders.................... 11
SECTION 2.13. Real Property...................................... 11
SECTION 2.14. Tangible Personal Property......................... 11
SECTION 2.15. Investment Assets.................................. 11
SECTION 2.16. Intellectual Property Rights....................... 12
SECTION 2.17. Contracts.......................................... 12
SECTION 2.18. Insurance.......................................... 13
SECTION 2.19. Employees; Labor Relations......................... 13
SECTION 2.20. Environmental Matters.............................. 14
SECTION 2.21. Brokers............................................ 14
SECTION 2.22. Related Party Transaction.......................... 15
SECTION 2.23. Registration Rights................................ 15
SECTION 2.24. Disclosure......................................... 15
ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE INVESTORS.......... 16
SECTION 3.01. Corporate Existence................................ 16
SECTION 3.02. Authority.......................................... 16
SECTION 3.03. No Conflicts....................................... 16
SECTION 3.04. Governmental Approvals and Filings................. 16
SECTION 3.05. Legal Proceedings.................................. 17
SECTION 3.06. Investment Purpose................................. 17
SECTION 3.07. Brokers............................................ 17
ARTICLE IV COVENANTS AND OTHER AGREEMENTS............................ 17
SECTION 4.01. Covenants of the Warrantors........................ 17
SECTION 4.02. Covenants of the Investors......................... 19
SECTION 4.03. Mutual Covenants................................... 19
ARTICLE V CONDITIONS TO CLOSING...................................... 20
SECTION 5.01. Conditions to Each Party's Obligations............. 20
SECTION 5.02. Conditions to Obligations of the Investor.......... 20
SECTION 5.03. Conditions to Obligations of the Company........... 22
ARTICLE VI SURVIVAL; NO OTHER REPRESENTATIONS........................ 22
SECTION 6.01. Survival of Representations and Warranties......... 22
SECTION 6.02. No Other Representations........................... 22
ARTICLE VII INDEMNIFICATION.......................................... 23
SECTION 7.01. Indemnification.................................... 23
SECTION 7.02. Method of Asserting Claims......................... 24
SECTION 7.03. Exclusivity........................................ 26
SECTION 7.04. No Consequential Damages........................... 27
SECTION 7.05. Limitation of Liability............................ 27
ARTICLE VIII TERMINATION............................................. 27
SECTION 8.01. Termination........................................ 27
SECTION 8.02. Effect of Termination.............................. 27
ARTICLE IX DEFINITIONS............................................... 28
SECTION 9.01. Defined Terms...................................... 28
SECTION 9.02. Construction of Certain Terms and Phrases.......... 35
ARTICLE X MISCELLANEOUS.............................................. 36
SECTION 10.01. Notices............................................ 36
SECTION 10.02. Entire Agreement................................... 36
SECTION 10.03. Expenses........................................... 37
SECTION 10.04. Public Announcements............................... 37
SECTION 10.05. Amendment and Waiver............................... 37
SECTION 10.06. No Third Party Beneficiary......................... 37
SECTION 10.07. No Assignment; Binding Effect...................... 37
SECTION 10.08. Enforcement of Agreement........................... 38
SECTION 10.09. Headings........................................... 38
SECTION 10.10. Governing Law; Dispute Resolution.................. 38
SECTION 10.11. Invalid Provisions................................. 38
SECTION 10.12. Counterparts....................................... 39
Schedule I Schedule of the Investors
Schedule II Disclosure Schedule
Exhibit A Transaction Documents
Exhibit B Amended and Restated Shareholders Agreement
Exhibit C Amended Articles
Exhibit D Warrant Side Letter
Exhibit E Additional Investor Representations and Warranties
This AMENDED AND RESTATED SERIES B PREFERRED SHARE PURCHASE AGREEMENT,
dated as of December 15, 2006 (this "AGREEMENT"), is entered into by and among
Yingli Green Energy Holding Company Limited, an exempted company with limited
liability incorporated and existing under the laws of the Cayman Islands (the
"COMPANY"), Yingli Power Holding Company Ltd., a company with limited liability
incorporated and existing under the laws of the British Virgin Islands (the
"HOLDCO"), ▇▇. ▇▇▇▇▇▇▇▇▇ ▇▇▇▇ (the "FOUNDER") and the investors listed on
Schedule I attached to hereto (the "INVESTORS"). Capitalized terms not otherwise
defined herein have the meanings set forth in Section 9.01.
WITNESSETH:
WHEREAS, the Company, the Holdco, the Founder and Baytree
(Investments) Mauritius Pte Ltd. entered into the Series B Preferred Share
Purchase Agreement, dated December 5, 2006 (the "PRIOR SERIES B PURCHASE
AGREEMENT");
WHEREAS, the parties to the Prior Series B Purchase Agreement desire
to amend and restate the Prior Series B Purchase Agreement in its entirety
pursuant to the terms set forth in this Agreement;
WHEREAS, The parties to the Prior Series B Purchase Agreement have
agreed that the Prior Series B Purchase Agreement shall be of no further force
and effect and further that the rights granted to the parties hereto under this
Agreement shall supersede the rights granted to such parties under the Prior
Series B Purchase Agreement
WHEREAS, the Company wishes to sell and the Investors wish to purchase
a certain number of Series B Preferred Shares, US$0.01 par value per share, of
the Company (the "SERIES B PREFERRED SHARES") on terms and subject to the
conditions set forth in this Agreement.
NOW, THEREFORE, in consideration of the mutual covenants and
agreements set forth in this Agreement, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the
parties hereto hereby amend and restate the Prior Series B Purchase Agreement in
its entirety as follows:
ARTICLE I
SALE OF SHARES AND CLOSING
SECTION 1.01. Purchase and Sale. Subject to the conditions set forth
in this Agreement, each Investor agrees to purchase, severally but not jointly,
and the Company agrees to sell and issue to each such Investor, at the Closing
the number of Series B Preferred Shares set forth opposite such Investor's name
on Schedule I, at a purchase price of US$4.835 per share. The Series B Preferred
Shares issued and sold to the Investors pursuant to this Agreement shall be
referred to as the "SHARES".
1
SECTION 1.02. Closing. The Closing shall take place not later than
five (5) Business days after the satisfaction or waiver of the conditions set
forth in Articles V or such other date agreed by the parties hereto (such date
being the "CLOSING DATE") at the offices of ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ & ▇▇▇▇▇▇▇▇ LLP, 7/F
ICBC Tower, 3 Garden Road, Central Hong Kong, or at such other time and place as
the Investors and the Company mutually agree.
SECTION 1.03. Purchase Price. Subject to Section 1.04 hereof, upon the
terms and subject to the conditions of this Agreement, on the Closing Date, each
Investor shall pay the Company the sum of (i) the purchase price (the "PURCHASE
PRICE") set forth opposite such Investor's name on Schedule I; provided,
however, the Advance Payment made by each Advance Payment Investor shall be
deemed to constitute the payment by such Advance Payment Investor of its
Purchase Price on the Closing Date and (ii), except in the case of the Lead
Series B Shareholder, the Pro Rata Expense applicable to such Investor. The
Purchase Price shall be paid by each Investor (other than an Advance Payment
Investor) as follows:
(a) An amount set forth under the heading of "Released Amount"
opposite such Investor's name on Schedule I attached hereto (the "RELEASED
AMOUNT") shall be paid in immediately available funds by wire transfer to an
account to be designated by the Company in writing on or prior to the Closing
Date; and
(b) The remaining amount of the Purchase Price (the "ESCROW AMOUNT")
shall be paid in immediately available funds by wire transfer to an escrow
account established pursuant to the Escrow Agreement.
The Pro Rata Expense shall be paid by each Investor (other than the
Lead Series B Investor) in immediately available funds by wire transfer to an
account to be designated by the Company and to be notified by the Lead Series B
Investor in writing to each Investor (other than the Lead Series B Investor) on
or prior to the Closing Date.
SECTION 1.04. Share Certificate.
(a) At the Closing, in exchange for the payment to the Company of the
Released Amount by each Investor (other than an Advance Payment Investor) and
the Pro Rata Expense by each Investor (other than the Lead Series B Shareholder)
pursuant to Section 1.03(a) hereof, the Company shall deliver or cause to be
delivered to such Investor original share certificates (the "RELEASED SHARE
CERTIFICATES") representing the number of Shares set forth under the heading of
the "Released Shares" opposite such Investor's name on Schedule I attached
hereto (the "RELEASED SHARES").
(b) Subject to the escrow arrangement described in Section 1.06 below,
at the Closing, in exchange for the payment to the Escrow Agent of the Escrow
Amount by each Investor (other than an Advance Payment Investor) pursuant to
Section 1.03(b) hereof, the Company shall deliver or cause to be delivered to
such Investor original share certificates (the "ESCROW SHARE CERTIFICATES")
representing the number of
2
Shares set forth under the heading of "Escrow Shares" opposite such Investor's
name on Schedule I attached hereto (the "ESCROW SHARES").
(c) At the Closing, in exchange for the advance payment of the
Purchase Price and the Pro Rata Expense to the Company by each Advance Payment
Investor prior to the date of this Agreement, the Company shall deliver or cause
to be delivered to such Advance Payment Investor original share certificates
(the "ADVANCE PAYMENT SHARE CERTIFICATES") representing the number of Shares set
forth under the heading of the "Shares Being Purchased" opposite such Advance
Payment Investor's name on Schedule I attached hereto (the "ADVANCE PAYMENT
SHARES").
(d) The Company shall exercise its best efforts to pay to the Lead
Series B Shareholder the aggregate sum of the Pro Rata Expenses received by the
Company at or prior to the Closing as soon as reasonably practicable, but in no
event within two (2) Business Days following the Closing. Following the payment
of such sum of the Pro Rata Expenses, the Company shall be under no obligation
whatsoever to the Lead Series B Investor with respect to the Pro Rata Expenses
that remains unpaid to the Lead Series B Investor.
(e) For the avoidance of doubt, the rights and obligations of the
Company set forth in this Section 1.04(a) and (c) shall apply severally and not
jointly to each Investor, and the failure of any Investor or Investors (other
than an Advance Payment Investor) to pay the Released Amount or the failure of
any Investor or Investors (other than an Lead Series B Shareholder) to pay its
or their Pro Rata Expense shall in no way whatsoever affect the Company's right
and obligations under this Agreement to effect the Closing with respect to the
other Investors.
SECTION 1.05. Use of Proceeds.
(a) The Company shall not use the net proceeds from the Purchase Price
(the "PROCEEDS") for any purpose other than to (i) make an interest-bearing loan
(the "SHAREHOLDER LOAN") to Tianwei Yingli in an aggregate principal amount
equal to the sum (or its Renminbi equivalent) of (x) the Released Amounts paid
by all of the Investors (other than the Advance Payment Investors) and (y) the
aggregate amount of all Advancement Payments paid by each Advance Payment
Investor and (ii) in accordance with that certain Joint Venture Contract, dated
August 25, 2006, by and between Baoding Tianwei Baobian Electric Co., Ltd. and
the Company, as amended from time to time (the "JOINT VENTURE CONTRACT"),
increase the Company's equity ownership in Tianwei Yingli (the "CAPITAL
INCREASE"). The amount of the Capital Increase shall be an amount (or its
Renminbi equivalent) equal to the difference between the total amount of the
Proceeds and the aggregate principal amount of the Shareholder Loan, provided
that if the Shareholder Loan is fully converted into the Company's equity
ownership in Tianwei Yingli following approval thereof by relevant Government or
Regulatory Authorities, the amount of the Capital Increase shall be the entire
amount of the Proceeds. The Company shall, and the Warrantors shall procure the
Company and Tianwei Yingli to, apply for the approval of relevant Government or
Regulatory Authorities to convert the entire principal
3
and interest accrued under the Shareholder Loan into an equity interest in
Tianwei Yingli in the form of a Capital Increase.
(b) Following the Shareholder Loan and the Capital Increase, the
Company shall procure that the Subsidiaries use the Proceeds for the purchase of
silicon raw materials, capital expenditure related to the expansion of the
production capacity of the Subsidiaries, repayment of loans of the Subsidiaries
made by financial institutions then due and other general corporate purposes of
the Subsidiaries in accordance with the Amended Articles and the Shareholders
Agreement. Subject to Section 1.06 hereof and the Escrow Agreement, the Proceeds
shall be deposited in an account of the Company at a bank located outside of the
PRC and shall be withdrawn only by the Company's authorized signatories subject
to the prior written approval by the Series B Nominee (as defined in the
Shareholders Agreement), which approval shall not be unreasonably withheld,
provided such approval by the Series B Nominee shall be required with respect to
the withdrawal of the Proceeds for the purpose of effecting the Shareholder Loan
and the Capital Increase.
SECTION 1.06. Escrow Arrangement.
(a) For the purpose of securing satisfaction by the Warrantors of
certain conditions subsequent set forth in Section 1.06(c) (the "CONDITIONS
SUBSEQUENT"), the Warrantors and the Investors (other than the Advance Payment
Investors) shall enter into a mutually satisfactory escrow agreement (the
"ESCROW AGREEMENT") with an escrow agent (the "ESCROW AGENT") selected by the
Warrantors and reasonably satisfactory to the Investors. The Warrantors and the
Investors agree that the Escrow Amount and the Escrow Share Certificates shall
be held, free and clear of any and all Liens other than subject to the Escrow
Agreement, as of the Closing Date, in an escrow account established pursuant to
the Escrow Agreement. For the avoidance of doubt, the Shares issued to the
Advance Payment Investors shall not be subject to the provisions of this Section
1.06.
(b) The Escrow Amount and the Escrow Share Certificates shall be held
in an escrow by the Escrow Agent subject to the terms of the Escrow Agreement
until the satisfaction or waiver of the Conditions Subsequent, upon which the
Escrow Amount (together with any accrued interest paid by the Escrow Agent)
shall be immediately released by the Escrow Agent to the Company as otherwise
provided in Section 1.03 and the Escrow Share Certificates shall be immediately
released by the Escrow Agent to the Investors as otherwise provided in Section
1.04; provided that, in the event that this Agreement is terminated by the Lead
Series B Investor pursuant to Section 8.01(b) hereof, the Escrow Amount
(together with any accrued interest paid by the Escrow Agent) shall be returned
by the Escrow Agent to the Investors, and the Escrow Share Certificates shall be
returned to the Company, each pursuant to Section 8.02(b). For the avoidance of
doubt, upon the return of the Escrow Share Certificates, the Investors shall not
be entitled to any right to or interest in the Escrow Shares evidenced by such
Escrow Share Certificates.
4
(c) Unless otherwise waived by the Lead Series B Shareholder, the
Conditions Subsequent shall be deemed to be satisfied when the Company shall
have (i) entered into (x) an amendment to the joint venture contract between the
Company and Baoding Tianwei Baobian Electrics Co., Ltd (the "JV CONTRACT
AMENDMENT") and (y) an amendment to the articles of association of Tianwei
Yingli (the "JV ARTICLE AMENDMENT"), in each case to the reasonable satisfaction
of the Lead Series B Shareholder; (ii) delivered a legal opinion to the
reasonable satisfaction of the Investors from the PRC counsel of the Company
that the Company has filed with, and obtained requisite Licenses, approvals and
consents from the relevant Governmental or Regulatory Authorities (including,
without limitation, the governmental approvals and filings as set forth in
Section 2.07 of the Disclosure Schedule) and any other third parties to effect
the JV Contract Amendment, the JV Article Amendment and the Capital Increase;
and (iii) the Shareholder Loan shall have been funded by the Company to Tianwei
Yingli prior to the Capital Increase and duly registered with the Baoding Branch
of the State Administration of Foreign Exchange.
(d) Each Investor (other than an Advance Payment Investor) hereby
appoints the Lead Series B Shareholder as its representative with respect to the
negotiation, execution and performance of the Escrow Agreement, and the Lead
Series B Shareholder accepts such appointment. The Lead Series B Shareholder,
acting in accordance with this Agreement, shall have the authority and power to
act on behalf of other Investors (other than the Advance Payment Investors) with
respect to the Escrow Agreement or other rights or obligations arising from and
taken pursuant to the Escrow Agreement, provided that such actions do not
increase or disproportionately affect an Investor's obligations hereunder in
regards to the obligations of all Investors hereunder. Each Investor (other than
an Advance Payment Investor) shall be bound by all actions taken by the Lead
Series B Shareholder in accordance with this Agreement, in connection with the
Escrow Agreement. Each of the Investors (other than the Lead Series B
Shareholder and the Advanced Payment Investors) agrees, severally and not
jointly, to indemnify, defend and hold harmless the other Lead Series B
Shareholder to the fullest extent permitted by law from and against any and all
Losses of the Lead Series B Shareholder resulting from or arising out of the
Lead Series B Shareholder's action on behalf of other Investors with respect to
the Escrow Agreement or other rights or obligations arising from and taken
pursuant to the Escrow Agreement in the absence of willful misconduct or bad
faith on the part of the Lead Series B Shareholder, provided, further that, such
Losses shall be borne pro rata by each of the Investors (including the Lead
Series B Shareholder) in proportion to such Investor's applicable Escrow Amount.
SECTION 1.07. Further Assurances. At any time or from time to time
after the Closing, each party hereto shall, at the expense of the party making
such request, execute and deliver such other documents and instruments, provide
such materials and information and take such other actions as may reasonably be
necessary, proper or advisable, to the extent permitted by Law, to fulfill its
obligations under this Agreement and the Transaction Documents.
5
ARTICLE II
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
The Company, the Holdco and the Founder (together, the "WARRANTORS")
hereby jointly and severally represent and warrant to each Investor that the
statements contained in this Article II are true, correct and complete as of the
date of this Agreement and, unless otherwise provided herein, the date of the
Closing, except as set forth in the Disclosure Schedule attached hereto as
Schedule II, which exceptions shall be deemed to be representations and
warranties as if made hereunder:
SECTION 2.01. Power and Authority. Each of the Company and the Holdco
has full corporate power and authority to execute and deliver this Agreement, to
perform its obligations hereunder and to consummate the transactions
contemplated hereby, including without limitation the sale and issuance of the
Shares, the Warrants and the Warrant Shares upon the exercise of the Warrants
pursuant to the Transaction Documents.
SECTION 2.02. Execution and Delivery. The execution and delivery by
each of the Company and Holdco of the Transaction Documents and the performance
by the Company and the Holdco of their respective obligations under the
Transaction Documents and any other agreements, instruments and documents
required to be executed and delivered with respect to the transactions
contemplated in the Transaction Documents have been duly and validly authorized
by or on behalf of the Company and/or the Holdco (as applicable), no other
action on the part of the Company, the Holdco or their respective shareholders
being necessary except as expressly contemplated hereby. The Transaction
Documents have been duly and validly executed and delivered by each of the
Company and Holdco and assuming the due execution of the Transaction Documents
by other parties hereto, constitute legal, valid and binding obligations of each
of the Company and Holdco enforceable against each of the Company and the Holdco
in accordance with their respective terms.
SECTION 2.03. Corporate Existence of the Company. The Company is a
corporation duly incorporated, validly existing and in good standing under the
laws of the Cayman Islands, and has full corporate power and authority to
conduct its business as and to the extent now conducted and to own, use and
lease its Assets and Properties. The Company is duly qualified, licensed or
admitted to do business in each jurisdiction in which the ownership, use or
leasing of its Assets and Properties, or the conduct or nature of its business,
makes such qualification, licensing or admission necessary, except for those
jurisdictions in which the adverse effects of all such failures by the Company
to be qualified, licensed or admitted would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect.
SECTION 2.04. Company Capital Stock. Immediately prior to the Closing,
the authorized capital stock of the Company shall be US$10,000,000, consisting
of (a) 967,513,542 ordinary shares ("ORDINARY SHARES"), US$0.01 par value per
share,
6
of which 59,800,000 shares are issued and outstanding, (b) 8,081,081 shares of
Series A Preferred Shares, US$0.01 par value per share, all of which are issued
and outstanding, and (c) 24,405,377 shares of Series B Preferred Shares, US$0.01
par value per share, none of which are issued and outstanding. The Shares, when
issued, sold and delivered in accordance with the terms and for the
consideration set forth in this Agreement, shall be duly authorized and validly
issued, fully paid and nonassessable and free and clear of all Liens. The
Ordinary Shares issuable upon conversion of the Shares purchased under this
Agreement or upon the exercise of the Warrants issued in accordance with the
Warrant Side Letter have been duly and validly reserved for issuance and, upon
issuance in accordance with the terms of this Agreement and the Amended
Articles, shall be duly authorized and validly issued, fully paid and
nonassessable and free and clear of all Liens. The delivery of the Share
Certificates at the Closing representing the Shares in the manner provided in
Section 1.04 shall transfer to each Investor good and valid title to the Shares
purchased by such Investor, free and clear of all Liens other than restrictions
on the payment of dividends arising under applicable Law, restrictions on
transferability arising under applicable securities Laws and any Liens created
or suffered to exist by the Investor. Except the Warrants and as disclosed in
the Disclosure Schedule and except as provided in this Agreement, there are no
outstanding Options with respect to any shares of the Company. A complete list
of all outstanding shareholders, Option holders and other security holders of
the Company as of the Closing Date is provided in Section 2.04 of the Disclosure
Schedule.
SECTION 2.05. Subsidiaries.
(a) Each of the Subsidiaries is a corporation duly organized and
validly existing under the laws of its jurisdiction of incorporation and has
full corporate power and authority to conduct its business as and to the extent
now conducted and to own, use and lease its Assets and Properties. Each of the
Subsidiaries is duly qualified, licensed or admitted to do business in each
jurisdiction in which the ownership, use or leasing of its Assets and
Properties, or the conduct or nature of its business, makes such qualification,
licensing or admission necessary, except for those jurisdictions in which the
adverse effects of all such failures by any Subsidiary to be qualified, licensed
or admitted would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect. The Articles of Association of each
Subsidiary are valid and, to the extent required by applicable Laws, have been
approved by and filed with competent Governmental or Regulatory Authorities and
are in full force and effect.
(b) The Disclosure Schedule lists for each of the Subsidiaries its
jurisdiction of organization, the amount of its authorized capital stock or its
equivalent, the amount of its outstanding capital stock or its equivalent, and
the record owners of such outstanding capital stock or its equivalent. As of the
date hereof and as of the Closing Date, except as disclosed in the Disclosure
Schedule, all the outstanding shares of capital stock or its equivalent of each
of the Subsidiaries have been duly authorized and validly issued, are fully paid
and nonassessable and free and clear of all Liens. Except as disclosed in the
Disclosure Schedule, there are no outstanding Options or other
7
rights, agreements, arrangements or commitments to which any Subsidiary is a
party or by which any Subsidiary is bound relating to the issued or unissued
shares of capital stock or its equivalent of any Subsidiary.
(c) Each of (i) the transfer of the equity interest in Tianwei Yingli
held by Baoding Yingli Group Co., Ltd. to the Company as contemplated in Tianwei
Yingli's shareholders' resolutions dated August 25, 2006 and (ii) the increase
of the registered capital of Tianwei Yingli as contemplated in Tianwei Yingli's
board resolutions dated October 10, 2006 and November 13, 2006 were made in
compliance, in all material respects, with applicable PRC Laws and Orders
(including without limitation the M&A Regulations, the SAFE Circular 75 and the
PRC Laws governing state-owned assets).
(d) Except as set forth in the Disclosure Schedule, none of the
Subsidiaries is in receipt of any written notice from any relevant Governmental
or Regulatory Authority notifying the revocation of any Licenses issued to such
Subsidiary or requiring any remedial actions by such Subsidiary, except as would
not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect.
(e) Except as set forth in the Disclosure Schedule, none of the
Subsidiaries is in receipt of any written notice from any relevant Governmental
or Regulatory Authority notifying the revocation of any Licenses issued to it
for non-compliance or the need for compliance or remedial actions in respect of
the activities carried out by such Subsidiary.
SECTION 2.06. No Conflicts. Except as disclosed in the Disclosure
Schedule, the execution and delivery by each of the Warrantors and Tianwei
Yingli of the Transaction Documents (as applicable) do not, and the performance
by the Warrantors of their respective obligations under the Transaction
Documents, and the consummation of the transactions contemplated thereby shall
not, as of the date of this Agreement and as of the Closing Date:
(a) conflict with or result in a violation or breach of any of the
terms, conditions or provisions of the organizational documents of the Company,
the Holdco or any Subsidiary;
(b) conflict with or result in a violation or breach of any term or
provision of any Law or Order applicable to or any License of the Company, the
Holdco, any Subsidiary or any of their respective Assets and Properties in any
material respect; or
(c) (i) conflict with or result in a violation or breach of, (ii)
constitute a default under, (iii) require the Company, the Holdco or any
Subsidiary to obtain any consent, approval or action of, make any filing with or
give any notice to any Person as a result or under the terms of, (iv) result in
or give to any Person any right of termination, cancellation, acceleration or
modification in or with respect to, or (v) result in the creation or imposition
of any Lien upon the Company, the Holdco, any Subsidiary or any
8
of their respective Assets and Properties under, any Material Contract, in each
case, in any material respect.
SECTION 2.07. Governmental Approvals and Filings. Except as disclosed
in the Disclosure Schedule, no consent, approval or action of, filing with or
notice to any Governmental or Regulatory Authority on the part of the Company,
the Holdco or any Subsidiary is required in connection with the execution,
delivery and performance of the Transaction Documents or the consummation of the
transactions contemplated thereby. All Licenses required with respect to the
Subsidiaries have been duly obtained in accordance with the applicable Laws,
except where the failure to obtain such Licenses would not have a Material
Adverse Effect.
SECTION 2.08. Books and Records. The Company has made available to the
Investors prior to the execution of this Agreement complete and correct copies
of the organizational documents of the Company and each Subsidiary. The minute
books and other similar records of the Company and each Subsidiary as made
available to the Investors prior to the execution of this Agreement contain a
true and complete record, in all material respects, of all actions taken at all
meetings and by written consents in lieu of meetings of the stockholders, the
boards of directors and committees of the boards of directors of the Company and
each Subsidiary. The shareholders register of the Company and each Subsidiary as
made available to the Investors prior to the execution of this Agreement
accurately reflect all record issuances and transfers prior to the execution of
this Agreement of the capital stock of the Company and each Subsidiary. To the
Knowledge of the president, the directors, the vice presidents and the
department heads of the Company and Tianwei Yingli, the Books and Records of the
Company and each Subsidiary made available to the Investors prior to the
execution of this Agreement do not contain any untrue statement of a material
fact.
SECTION 2.09. Financial Statements and Condition
(a) Prior to the execution of this Agreement, the Company has made
available to the Investors true and complete copies of the Financial Statements.
The information contained in the Financial Statements shall be substantially
similar to the information contained in the audited consolidated balance sheets,
income statements and statements of cash flow of Tianwei Yingli for the years
ended on December 31, 2004 and 2005 (the "ACTUAL ANNUAL FINANCIAL STATEMENTS")
and the unaudited consolidated balance sheets, income statements and statements
of cash flow of Tianwei Yingli for the six months ended June 30, 2006 (the
"ACTUAL INTERIM FINANCIAL STATEMENTS"), each of which shall have been audited
(in the case of the Actual Annual Financial Statements) or reviewed (in the case
of the Actual Interim Financial Statements) by KPMG Huazhen and shall be
delivered to the Investors as soon as it is released by KPMG Huazhen but no
later than sixty (60) days following the Closing.
The net income for each of the years ended on December 31, 2004
and 2005 as indicated in the Actual Annual Financial Statements shall not be
less than ninety five percent (95%) of the net income for each of the
corresponding years indicated in the Financial Statements. The net income for
the six months ended on June 30, 2006 as
9
indicated in the Actual Interim Financial Statements shall not be less than
ninety percent (90%) of its counterpart for the corresponding period indicated
in the Financial Statements.
(b) Except for the execution and delivery of the Transaction Documents
and the transactions to take place pursuant thereto on or prior to the Closing
Date or as disclosed in the Disclosure Schedule, since June 30, 2006 until the
Closing Date, the business of the Company and the Subsidiaries has been operated
in all material respects in the ordinary course consistent with past practice
and there has not been any change in the Business or Condition of the Company
that has or would reasonably be expected to have a Material Adverse Effect.
(c) To the Knowledge of the Warrantors, except as reflected in the
Financial Statements described in paragraph (a) of this Section or as set forth
in the Disclosure Schedule, and except for Liabilities incurred in the ordinary
course of business consistent with past practice, neither the Company nor any
Subsidiary has any material Liabilities of any nature (whether accrued,
absolute, contingent or otherwise) required by US GAAP to be set forth on a
consolidated balance sheet of the Company or in the notes thereto.
SECTION 2.10. Taxes. Except as disclosed in the Disclosure Schedule,
as of the date hereof, (1) the Company and each Subsidiary have filed all Tax
returns and reports required to be filed by the Company and each Subsidiary, or
requests for extensions to file such returns or reports have been timely filed
or granted and have not expired; (2) all such Tax returns and reports are true,
correct and complete except as would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect; (3) there have been
no examinations or audits of any tax returns or reports by any applicable
Governmental or Regulatory Authority; and (4) there have been no written
communications from any applicable Governmental or Regulatory Authority. As of
the date hereof, except as disclosed in the Disclosure Schedule, the Company and
each Subsidiary have paid all Taxes shown as due on such Tax returns and reports
in all material respects. Further, each of the Company and its Subsidiaries has
duly withheld individual income taxes and adequately paid mandatory
contributions to the statutory welfare or social security funds on behalf of all
its employees, contractors and directors, in each case to the extent required by
applicable laws, in compliance with the applicable regulations in each
respective jurisdiction such that there shall be no default or underpayment in
respect of individual income taxes and mandatory contributions to the statutory
social security funds that has or would reasonably be expected to have a
Material Adverse Effect.
SECTION 2.11. Legal Proceedings. As of the date hereof, except as
disclosed in the Disclosure Schedule or except as would not reasonably be
expected to have, individually or in the aggregate, a Material Adverse Effect:
(a) there are no Actions or Proceedings pending or, to the Knowledge
of the Warrantors, threatened seeking to restrain, adjourn or otherwise prohibit
or make
10
illegal the consummation of any of the transactions contemplated by the
Transaction Documents; and
(b) there are no Actions or Proceedings pending or, to the Knowledge
of the Warrantors, threatened against, relating to or affecting the Company, any
Subsidiary or any of their respective Assets and Properties.
SECTION 2.12. Compliance With Laws and Orders. Except as disclosed in
the Disclosure Schedule or except as would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect, neither the Company
nor any Subsidiary has received any written communication since January 1, 2004
until the date hereof from any Governmental or Regulatory Authority that alleges
that the Company or any Subsidiary, as applicable, is in violation of or in
default under any Law or Order applicable to the Company or such Subsidiary. To
the Knowledge of the Warrantors, each of the Company and its Subsidiaries is in
compliance, in all material respects, with all Laws or Orders.
SECTION 2.13. Real Property.
(a) Except as disclosed in the Disclosure Schedule, each of the
Company and the Subsidiaries has good title to each parcel of real property
owned by it and is in possession of each such parcel of real property, together
with all buildings, structures, facilities, fixtures and other improvements
thereon, free and clear of any Lien other than the Permitted Liens that do not
materially impair the Company's or any Subsidiary's ownership or use of such
property.
(b) Except as disclosed in the Disclosure Schedule, each of the
Company and the Subsidiaries has a valid and subsisting leasehold estate in and
the right to quiet enjoyment of the real properties leased by it, free and clear
of any Liens other than the Permitted Liens (except by the Lessor) that do not
materially impair the Company's or any Subsidiary's use of such property.
SECTION 2.14. Tangible Personal Property. Except as disclosed in the
Disclosure Schedule or except as would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect, each of the Company
and the Subsidiaries is in possession of and has good title to, or has valid
leasehold interests in or valid rights under Contract to use, all tangible
personal property material to the Business or Condition of the Company, free and
clear of any Liens other than the Permitted Liens that do not materially impair
the Company's or any Subsidiary's ownership or use, as applicable, of such
property.
SECTION 2.15. Investment Assets. As of the date hereof, the Disclosure
Schedule lists each Investment Asset in excess of US$3 million held by the
Company or any Subsidiary in any Person which is not a Subsidiary. Except as
disclosed in the Disclosure Schedule, as of the date hereof, all such Investment
Assets listed on the Disclosure Schedule are owned by the Company or a
Subsidiary and are free and clear of
11
all Liens other than the Permitted Liens that do not materially impair the
Company's or any Subsidiary's ownership or use of such property.
SECTION 2.16. Intellectual Property Rights. As of the date hereof,
each of the Company and the Subsidiaries either has all right, title and
interest in or a valid and binding right under Contract to use the Intellectual
Property material to the Business or Condition of the Company (the "COMPANY
INTELLECTUAL PROPERTY"). As of the date hereof, (a) all registrations with and
applications to Governmental or Regulatory Authorities in respect of the Company
Intellectual Property owned by the Company or a Subsidiary are valid and in full
force and effect and (b) the execution of the Transaction Documents and the
consummation of the transactions contemplated thereby do not trigger any
restrictions on the direct or indirect transfer of any material Contract, or any
interest therein, held by the Company or any Subsidiary in respect of the
Company Intellectual Property. As of the date hereof, neither the Company nor
any Subsidiary has received notice that the Company or any Subsidiary is
infringing any Intellectual Property of any other Person in any material
respect; to the Knowledge of the Warrantors, no claim to such effect is pending
and has not been resolved; and as of the date hereof, to the Knowledge of the
Warrantors, neither the Company nor any Subsidiary is infringing any
Intellectual Property of any other Person in any material respect. Section 2.16
of the Disclosure Schedule contains a complete list of the Company Intellectual
Property.
SECTION 2.17. Contracts.
(a) As of the date hereof, the Disclosure Schedule contains a true and
complete list of each of the following Contracts to which the Company or any
Subsidiary is a party or by which any of their respective Assets and Properties
is bound (the "MATERIAL CONTRACTS"):
(i) Contracts providing for a commitment of employment or
consultation services for a specified or unspecified term or otherwise relating
to employment or termination of employment of each member of senior management
of the Company and the Subsidiaries;
(ii) Contracts containing any provision or covenant prohibiting
or materially limiting the ability of the Company or any Subsidiary to engage in
any business activity or compete with any Person or prohibiting or materially
limiting the ability of any Person to compete with the Company or any Subsidiary
or otherwise impairing, restricting or imposing conditions on the Company or any
Subsidiary's right to offer or sell products or services in specified
geographical areas or for specified time periods;
(iii) material partnership, joint venture, shareholders' or other
similar Contracts with any Person;
12
(iv) Contracts relating to Indebtedness of the Company or any
Subsidiary in excess of US$3 million;
(v) Contracts with distributors, manufacturers, suppliers or
sales agencies that involve a binding payment or obligation by or to the Company
or any Subsidiary of more than US$3 million annually;
(vi) Contracts relating to (A) the future disposition or
acquisition of any Assets and Properties individually or in the aggregate
material to the Business or Condition of the Company, other than dispositions or
acquisitions in the ordinary course of business, and (B) any merger or other
business combination (other than this Agreement);
(vii) Contracts between or among the Company and any Subsidiary
relating to Indebtedness or the provision of services between such entities;
(viii) Contracts with top five (5) distributors, manufacturers,
suppliers or sales agencies, which collectively account for at least seventy
percent (70%) of the supply of silicon to the Company and its Subsidiaries in
the aggregate as of the date of this Agreement; and
(ix) Contracts transferring or licensing any Company Intellectual
Property to or from the Company or any Subsidiary (other than licenses from
commercially readily available "off the shelf" computer software).
(b) As of the date hereof, none of the Contracts required to be
disclosed in the Disclosure Schedule has been terminated prior to the expiration
of the agreed minimum term by any party thereto nor, to the Knowledge of the
Warrantors as to any Contract the Company or any Subsidiary is a party, has any
party indicated its intention to terminate any of such Contracts. Except as
disclosed in the Disclosure Schedule, to the Knowledge of the Warrantors,
neither the Company nor any Subsidiary or any other party to such Contract is in
violation or breach of or default under any such Contract in any material
respect.
SECTION 2.18. Insurance. As of the date hereof, except as disclosed in
the Disclosure Schedule or except as would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect, no premiums are due
or have not been paid in relation to, and neither the Company nor any Subsidiary
has received any notice of cancellation or termination in respect of, or, to the
Knowledge of the Warrantors, is in default under, any insurance policy currently
in effect that insure the business, operations or employees of the Company or
any Subsidiary or affect or relate to the ownership, use or operation of any of
the Assets and Properties of the Company or any Subsidiary in any material
respect.
SECTION 2.19. Employees; Labor Relations. Except as disclosed in the
Disclosure Schedule, each of the employees of the Company and/or the
Subsidiaries
13
has entered into an employment contract with the Company or the applicable
Subsidiary in the form made available to the Investors prior to the Closing.
Except as disclosed in the Disclosure Schedule, neither the Company nor any of
its Subsidiaries is a party to or bound by any other currently effective
employment contract, deferred compensation agreement, bonus plan, incentive
plan, profit sharing plan, retirement agreement or other employee compensation
agreement. As of the date hereof, except as disclosed in the Disclosure
Schedule, there are no disputes pending or, to the Knowledge of the Company,
threatened in writing between the Company or any Subsidiary and any trade union
or other representatives of its employees, except in each case for such disputes
as would not reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect.
SECTION 2.20. Environmental Matters. As of the date hereof, except as
disclosed in the Disclosure Schedule:
(a) Neither the Company nor any Subsidiary has received any written
communication since January 1, 2003 until the date hereof from any Governmental
or Regulatory Authority that alleges that the Company or any Subsidiary, as
applicable, is not in compliance with applicable Environmental Laws in any
material respect, except for any non-compliance that has been settled or
resolved.
(b) To the Knowledge of the Company, neither the Company nor any
Subsidiary is in violation of or not in compliance with applicable Environmental
Laws in any material respect.
(c) To the Knowledge of the Company, each of the Company and the
Subsidiaries has obtained or maintains all environmental, health and safety
permits and governmental authorizations necessary for the construction of its
facilities and the conduct of its operations as currently conducted, as
applicable (collectively, the "ENVIRONMENTAL PERMITS"), and all such
Environmental Permits are in good standing or, where applicable, a renewal
application or an application for any new operations has been timely filed and
is pending agency approval, and the Company and the Subsidiaries are in
compliance with all terms and conditions of such Environmental Permits. To the
Knowledge of the Company, neither the Company nor any Subsidiary has received
any notice from any Governmental Authority that it will revoke, cancel,
withdraw, terminate, suspend, not renew, or modify any such Environmental
Permits.
(d) This Section 2.20 contains the sole and exclusive representations
and warranties of the Company with respect to environmental matters arising
under any Environmental Law.
SECTION 2.21. Brokers. All negotiations relating to this Agreement and
the transactions contemplated hereby have been carried out by the Company
directly with the Investors without the intervention of any Person on behalf of
the Company in such manner as to give rise to any valid claim by any Person
against the
14
Investor, the Company or any Subsidiary for a finder's fee, brokerage commission
or similar payment.
SECTION 2.22. Related Party Transaction. Except as disclosed in the
Disclosure Schedule, no Founder, officer or director of the Company or any
Subsidiary or any Affiliate of any such person has any agreement with the
Company or any Subsidiary (except for employment contracts), understanding,
proposed transaction with, or is indebted to, any Company or Subsidiary, nor is
any Company or Subsidiary indebted (or committed to make loans or extend or
guarantee credit) to any of such persons (other than for accrued salaries,
reimbursable expenses or other standard employee benefits). Except as disclosed
in the Disclosure Schedule, no Founder, officer or director of the Holdco, the
Company or any Subsidiary has any direct or indirect ownership interest in (i)
any Person with which the Company or any Subsidiary is affiliated, (ii) any
Person with which the Company or any Subsidiary has a business relationship,
(iii) any Person that competes with the Company or any Subsidiary or (iv) any
Person which purchases from or sells, licenses or furnishes to the Company or
any Subsidiary any goods, property, intellectual or other property rights or
services. Except as disclosed in the Disclosure Schedule, there is no agreement
between any Founder, the Holdco and any other shareholder with respect to the
ownership or control of the Company or any Subsidiary.
SECTION 2.23. Registration Rights. Except as provided in the
Disclosure Schedule, the Shareholders Agreement, the warrant, dated August 28,
2006, granted by the Company to TB Management Company Limited, the Warrants, and
any employee stock option plans to be adopted by the Company in contemplation of
the Qualified IPO, neither the Company nor any Subsidiary is under any
obligation to provide any rights to register under the U.S. Securities Act of
1933, as amended (the "SECURITIES ACT"), any of its presently outstanding
securities or any of its securities that may hereafter be issued or upon
exercise or conversion of its currently outstanding securities, including
piggyback rights, to any Person.
SECTION 2.24. Disclosure. The information provided by the Warrantors
to the Investors as part of the due diligence process in connection with the
negotiation and execution of the Transaction Documents, taken as a whole, are
true and accurate in all material respects. The information contained in the
Transaction Documents and any other written certificates or instruments
delivered by the Warrantors in connection with the transactions contemplated
therein, taken as a whole, is true and accurate in all material respects.
15
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF THE INVESTORS
Unless otherwise specified herein, each Investor hereby, with respect
to such Investor, severally but not jointly represents and warrants to the
Company as follows:
SECTION 3.01. Corporate Existence. Each Investor is an entity duly
organized, validly existing and in good standing under the laws of the
jurisdiction in which it has been organized. Each Investor has full corporate
power and authority to execute and deliver this Agreement, to perform its
obligations hereunder and to consummate the transactions contemplated hereby.
SECTION 3.02. Authority. The execution and delivery by each Investor
of this Agreement, and the performance by such Investor of its obligations
hereunder, have been duly and validly authorized by all necessary action on the
part of such Investor, no other action on the part of such Investor or its
equity holders being necessary. This Agreement has been duly and validly
executed and delivered by each Investor and constitutes a legal, valid and
binding obligation of such Investor enforceable against such Investor in
accordance with its terms.
SECTION 3.03. No Conflicts. The execution and delivery by each
Investor of this Agreement do not, and the performance by such Investor of its
obligations under this Agreement and the consummation of the transactions
contemplated hereby shall not:
(a) conflict with or result in a violation or breach of any of the
terms, conditions or provisions of the corporate organizational documents of
such Investor;
(b) conflict with or result in a violation or breach of any term or
provision of any Law or Order applicable to such Investor or any of its Assets
and Properties; or
(c) (i) conflict with or result in a violation or breach of, (ii)
constitute (with or without notice or lapse of time or both) a default under,
(iii) require such Investor to obtain any consent, approval or action of, make
any filing with or give any notice to any Person as a result or under the terms
of, (iv) result in or give to any Person any right of termination, cancellation,
acceleration or modification in or with respect to, or (v) result in the
creation or imposition of any Lien upon such Investor or any of its Assets and
Properties under, any Contract or License to which such Investor is a party or
by which any of its Assets and Properties is bound.
SECTION 3.04. Governmental Approvals and Filings. No consent, approval
or action of, filing with or notice to any Governmental or Regulatory Authority
on the part of any Investor is required in connection with the execution,
delivery and
16
performance of this Agreement or the consummation of the transactions
contemplated hereby.
SECTION 3.05. Legal Proceedings. There are no Actions or Proceedings
pending or, to the Knowledge of each Investor, threatened seeking to restrain,
enjoin or otherwise prohibit or make illegal the consummation of any of the
transactions contemplated by this Agreement.
SECTION 3.06. Investment Purpose. Each Investor is acquiring the
Shares solely for the purpose of investment and not with a view to, or for offer
or sale in connection with, any distribution thereof.
SECTION 3.07. Brokers. All negotiations relating to this Agreement and
the transactions contemplated hereby have been carried out by each Investor
directly with the Company without the intervention of any Person on behalf of
such Investor in such manner as to give rise to any valid claim by any Person
against the Company for a finder's fee, brokerage commission or similar payment.
SECTION 3.08. Additional Representations. In addition to the
representations and warranties set forth in Sections 3.01 through 3.07 above,
each Investor who is a U.S. person (as such term is defined by Regulation S
under the Securities Act), with respect to such Investor, severally but not
jointly, makes the representations and warranties set forth in Appendix E
attached hereto.
ARTICLE IV
COVENANTS AND OTHER AGREEMENTS
SECTION 4.01. Covenants of the Warrantors. The Warrantors covenant and
agree with each Investor that, at all times from and after the date hereof until
the Closing, the Company shall comply and the Warrantors shall procure the
compliance by the Company and Tianwei Yingli with all covenants and provisions
of this Section 4.01, except to the extent the Lead Series B Shareholder may
otherwise consent in writing, which consent shall not be unreasonably withheld,
delayed or conditioned.
(a) Regulatory and Other Approvals. The Warrantors shall, and shall
cause the Subsidiaries to, as promptly as reasonably practicable, (i) obtain all
consents, approvals or actions of, make all filings with and give all notices to
Governmental or Regulatory Authorities or any other Person required of the
Company or any Subsidiary to consummate the transactions contemplated in the
Transaction Documents, including without limitation those described in the
Disclosure Schedule and the filing under the SAFE Circular 75, which shall be
obtained no later than ▇▇▇▇▇ ▇▇, ▇▇▇▇, (▇▇) provide such other information and
communications to such Governmental or Regulatory Authorities or other Persons
as such Governmental or Regulatory Authorities or other Persons may reasonably
request in connection therewith and (iii) provide reasonable
17
cooperation to the Investors in connection with the performance of its
obligations under Section 4.02. The Company shall provide prompt notification to
the Investors when any such consent, approval, action, filing or notice referred
to in clause (i) above is obtained, taken, made or given, denied, rejected or
disapproved, as applicable, and shall advise the Investors of any communications
(and, unless precluded by Law, provide copies of any such communications that
are in writing) with any Governmental or Regulatory Authority or other Person
regarding any of the transactions contemplated by the Transaction Documents.
(b) Conduct of Business. The Company and each Subsidiary shall conduct
its business in the ordinary course consistent with past practice. Without
limiting the generality of the foregoing, between the date of this Agreement and
the Closing Date, the Company shall use, and the Warrantors shall cause each
Subsidiary to use their best efforts to (i) preserve intact the present business
organization and reputation of the Company and the Subsidiaries, respectively,
in all material respects, (ii) keep available (subject to dismissals and
retirements in the ordinary course of business) the services of the key officers
and employees of the Company and the Subsidiaries, respectively, (iii) maintain
the respective Assets and Properties of the Company and the Subsidiaries in
working order and condition consistent with past custom and practice, ordinary
wear and tear excepted, and (iv) maintain the goodwill of key customers,
suppliers and lenders and other Persons with whom the Company and any Subsidiary
otherwise has significant business relationships.
(c) Fulfillment of Conditions. The Warrantors shall take all
commercially reasonable steps necessary or desirable and proceed diligently and
in good faith to satisfy each condition to the obligations of the Investors
contained in this Agreement and shall not take or fail to take any action that
would reasonably be expected to result in the non-fulfillment of any such
condition.
(d) Delivery of Financial Statements. As promptly as practicable, but
no later than one hundred twenty (120) days, after the end of each of 2006 and
2007, the Company shall deliver to the Investors audited consolidated balance
sheets, income statements and statements of cash flow of the Company, in each
case prepared in accordance with US GAAP, provided that if such consolidated
financial statements of the Company are not available, the Company shall deliver
audited consolidated balance sheets, income statements and statements of cash
flow of Tianwei Yingli, in each case prepared in accordance with US GAAP.
(e) Amended and Restated Articles of Association. The Warrantors shall
take all necessary steps to file or register the Company's Amended Articles in
the form reasonably satisfactory to the Lead Series B Shareholder with
applicable Governmental and Regulatory Authorities within five (5) Business Days
after the Closing.
(f) Register of Members. Notwithstanding anything contrary herein, the
Warrantors shall, on the Business Day immediately following the Closing Date,
deliver a copy of its registers of the members, directors, officers and holders
of warrants
18
of the Company, certified by the Chief Executive Officer as true, complete,
accurate and as in effect immediately after the Closing. The register of members
and register of directors delivered under this Section 4.01(f) shall reflect the
issuance of the Shares pursuant to this Agreement and the election of the Series
B Nominee (as defined in the Shareholders Agreement), respectively.
SECTION 4.02. Covenants of the Investors. Unless otherwise specified
herein, each Investor, with respect to such Investor, covenants and agrees with
the Company that, at all times from and after the date hereof until the Closing,
such Investor shall comply with all covenants and provisions of this Section
4.02, except to the extent the Company may otherwise consent in writing, which
consent shall not be unreasonably withheld, delayed or conditioned.
(a) Regulatory and Other Approvals. Each Investor shall as promptly as
practicable (i) take all commercially reasonable steps necessary or desirable to
obtain all applicable consents, approvals or actions of, make all filings with
and give all notices to Governmental or Regulatory Authorities or any other
Person required of such Investor to consummate the transactions contemplated
hereby, (ii) provide such other information and communications to such
Governmental or Regulatory Authorities or other Persons as such Governmental or
Regulatory Authorities or other Persons may reasonably request in connection
therewith and (iii) provide reasonable cooperation to the Company in connection
with the performance of its obligations under this Section 4.02. Each Investor
shall provide prompt notification to the Company when any such consent,
approval, action, filing or notice referred to in clause (i) above is obtained,
taken, made or given, as applicable, and shall advise the Company of any
communications (and, unless precluded by Law, provide copies of any such
communications that are in writing) with any Governmental or Regulatory
Authority or other Person regarding any of the transactions contemplated by this
Agreement.
(b) Fulfillment of Conditions. Each Investor shall take all
commercially reasonable steps necessary or desirable and proceed diligently and
in good faith to satisfy each condition to the obligations of the Company
contained in this Agreement and shall not take or fail to take any action that
would reasonably be expected to result in the non-fulfillment of any such
condition.
SECTION 4.03. Mutual Covenants. Each party hereto covenants and agrees
with the other party that, at all times from and after the date hereof until the
Closing, such party shall comply with all covenants and provisions of this
Section 4.03, except to the extent each other party may otherwise consent in
writing, which consent shall not be unreasonably withheld, delayed or
conditioned.
(a) Confidentiality. Each party hereto shall hold, and shall cause its
representatives to hold, in confidence this Agreement, the Transaction
Documents, all documents and information furnished to it by or on behalf of the
other parties in connection with the transactions contemplated hereby and shall
continue to be bound the
19
terms of the confidentiality agreement with the Company respectively entered by
each Investor, the terms of which are incorporated herein by reference.
(b) Publicity. No party hereto shall make any announcement regarding
this Agreement or the transactions contemplated hereby without the prior written
consent of the other parties, except as may be required pursuant to applicable
Law and except pursuant to Section 10.04.
ARTICLE V
CONDITIONS TO CLOSING
SECTION 5.01. Conditions to Each Party's Obligations. The obligation
of any of the parties hereto to consummate the transactions contemplated by this
Agreement is subject to the fulfillment, at or before the Closing, of each of
the following conditions (all or any of which may be waived in whole or in part
by the Company and the Lead Series B Shareholder):
(a) Orders and Laws. There shall not be in effect on the Closing Date
any Order or Law restraining, enjoining or otherwise prohibiting or making
illegal the consummation of any of the transactions contemplated by this
Agreement.
SECTION 5.02. Conditions to Obligations of the Investor. The
obligation of each Investor to purchase Shares at the Closing pursuant to this
Agreement is subject to the fulfillment, at or before the Closing, of each of
the following conditions (all or any of which may be waived in whole or in part
by such Investor in its sole discretion):
(a) Representations and Warranties. The representations and warranties
made by the Warrantors in this Agreement shall be true and correct in all
material respects on and as of the Closing Date as though made on and as of the
Closing Date (or, in the case of representations and warranties made as of a
specified date earlier than the Closing Date, on and as of such earlier date).
(b) Performance. The Warrantors shall have performed and complied
with, in all material respects, the agreements, covenants and obligations
required by this Agreement to be so performed or complied with by the Warrantors
at or before the Closing.
(c) No Material Change. Since June 30, 2006, there shall not have
occurred any change, event or condition that, individually or taken as a whole,
has, or that could reasonably be expected to have a Material Adverse Effect.
(d) Officer's Certificate. The Company's chief executive officer shall
deliver to the Investors at the Closing a certificate (i) certifying that the
conditions specified in Sections 5.02(a), 5.02(b), 5.02(c) and 5.02(j) have been
fulfilled; and (ii)
20
attaching a copy of the Amended Articles which shall be effective upon the
Closing.
(e) Transaction Documents. Except for the Amended Articles, the JV
Contract Amendment and the JV Article Amendment, each party to each Transaction
Document shall have duly executed and delivered each of the Transaction
Documents to which it is a party, which shall each be substantially similar to
the respective forms attached hereto as exhibits.
(f) Memorandum and Articles of Association. The Amended Articles,
which shall be substantially in the form attached hereto as Exhibit C and be
effective upon the Closing, shall have been duly adopted by all necessary
actions of the board of directors and shareholders of the Company.
(g) Opinion of Counsel. The Investors shall have received as of the
Closing Date the opinions of each of ▇▇▇▇▇▇▇ ▇▇▇▇ & ▇▇▇▇▇▇▇, Cayman Islands
counsel to the Company, and Fangda Partners, the PRC counsel to the Company,
both dated as of the Closing Date, to the reasonable satisfaction of the
Investors.
(h) Issuance of New Shares. Prior to the Closing, the Company shall
not, and the Warrantors shall procure the Company not to, have issued or
authorized the issuance of any Ordinary Shares or Series B Preferred Shares
other than as set forth in Section 2.04 hereof.
(i) Series B Directors. All necessary actions shall have been taken to
appoint a representative of the holders of the Series B Preferred Shares to each
of the board of directors of the Company and Tianwei Yingli, and to each
committee of the board of the Company, effective as of the Closing Date.
(j) Confidential Submission. The Company shall have submitted to the
United States Securities and Exchange Commission on a confidential basis a draft
registration statement on Form F-1 in connection with the initial public
offering of the Company's equity securities on the New York Stock Exchange as
lead-managed, as of the date of such submission, by the underwriters identified
in the copy of the draft registration statement on Form F-1 provided to the Lead
Series B Shareholder on November 18, 2006.
(k) Warrant Side Letter. The Company, the Holdco, the Founder and the
Lead Series B Shareholder shall have entered into a side letter relating, among
others, to the issuance of certain warrants substantially in the form attached
hereto as Exhibit D (the "WARRANT SIDE LETTER") or as otherwise agreed by the
Lead Series B Shareholder.
(l) Funding of the CB Proceeds. At least US$62,000,000 of the proceeds
from the issuance of that certain US$85,000,000 Bonds due 2008 issued by the
Company under the Trustee Deed, dated November 13, 2006, between the Company and
DB Trustees (Hong Kong) Limited, shall have been funded by the Company into
Tianwei Yingli in the form of registered capital to increase the percentage of
the Company's
21
equity ownership in Tianwei Yingli to at least 62.13%, as evidenced by a capital
verification report issued by a PRC certified public accountant and an updated
business license of Tianwei Yingli to such effect.
SECTION 5.03. Conditions to Obligations of the Company. The obligation
of the Company to consummate the transactions contemplated by this Agreement is
subject to the fulfillment, at or before the Closing, of each of the following
conditions (all or any of which may be waived in whole or in part by the Company
in its sole discretion); provided that the failure to fulfill any of such
conditions by an Investor other than the Lead Series B Shareholder shall not
affect the ability of the Lead Series B Shareholder to consummate the
transactions contemplated by this Agreement with respect to the Lead Series B
Shareholder.
(a) Representations and Warranties. The representations and warranties
made by each Investor in this Agreement, taken as a whole, shall be true and
correct in all material respects on and as of the Closing Date as though made on
and as of the Closing Date.
(b) Performance. Each Investor shall have performed and complied with,
in all material respects, the agreements, covenants and obligations required by
this Agreement to be so performed or complied with by such Investor at or before
the Closing.
ARTICLE VI
SURVIVAL; NO OTHER REPRESENTATIONS
SECTION 6.01. Survival of Representations and Warranties. The
representations and warranties of the Company contained in Article II and in the
Disclosure Schedule shall survive only until the first anniversary of the
Closing, except that any representation or warranty that would otherwise
terminate in accordance with this sentence shall continue to survive if a Claim
Notice or Indemnity Notice (as applicable) shall have been timely given in good
faith based on facts reasonably expected to establish a valid claim under
Article VII on or prior to such termination date, until the related claim for
indemnification has been satisfied or otherwise resolved as provided in Article
VII.
SECTION 6.02. No Other Representations. Except those representations
and warranties contained in Article II as qualified by the Disclosure Schedule,
it is the explicit intent of each party hereto that the Company is making no
representation or warranty whatsoever, express or implied, at law or in equity,
whether under contract, tort or other applicable law, in respect of the
Business, the Company or any Subsidiary, or any of their respective Assets and
Properties, Liabilities or operations. In addition, the Company makes no
representation or warranty to the Investors with respect to any financial
projection or forecast relating to the Business or Condition of the Company
provided by or on behalf of the Company to the Investors or any of their
22
Affiliates or Representatives, provided, that, such financial projection or
forecast were prepared in good faith. With respect to any projection or forecast
with respect to the Company and the Subsidiaries or the Business delivered by or
on behalf of the Company to the Investors or any of their Affiliates or
Representatives, each Investor acknowledges that (a) there are uncertainties
inherent in attempting to make such projections and forecasts, (b) it is
familiar with such uncertainties, (c) it is taking full responsibility for
making its own evaluation of the adequacy and accuracy of all such projections
and forecasts furnished to it and (d) it shall have no claim against the Company
or any of their Affiliates or Representatives with respect thereto, except where
it is determined that such projection or forecast were not prepared in good
faith.
ARTICLE VII
INDEMNIFICATION
SECTION 7.01. Indemnification.
(a) Following the Closing, subject to paragraphs (c) and (d) of this
Section, Section 7.03 and the other Sections of this Article VII, the Warrantors
shall jointly and severally indemnify each Investor in respect of, and hold it
harmless from and against, any and all Losses suffered, incurred or sustained by
it or to which it becomes subject, resulting from, arising out of or relating to
any breach of representation or warranty or non-fulfillment of or failure to
perform any covenant or agreement on the part of the Warrantors made in this
Agreement.
(b) Notwithstanding anything to the contrary contained in this
Agreement, no amounts of indemnity shall be payable by the Warrantors as a
result of any Losses arising under paragraph (a) of this Section 7.01:
(i) with respect to any claim, unless and until the aggregate
amount of Losses suffered cumulatively by any and all Investors exceeds US$2
million, in which case each Investor shall be entitled to indemnification of the
entire amount of Losses suffered by it subject to the terms and conditions of
Section 7.01;
(ii) with respect to any Investor, to the extent it arises from
or was caused by actions taken by such Investor or any of its Affiliates; or
(iii) with respect to any Investor, to the extent that such
Investor had been compensated for such Loss.
(c) Notwithstanding anything to the contrary contained in this
Agreement, the Warrantors shall, in no circumstance, be obligated hereunder to
indemnify any Investor in respect of any and all Losses in the aggregate in an
amount in excess of the sum of (i) the Purchase Price paid by such Investor and
(ii) an amount representing 12% of the Purchase Price paid by such Investor, as
computed on an annualized basis.
23
(d) Notwithstanding anything to the contrary contained in this
Agreement, this Article VII shall survive any termination of this Agreement.
SECTION 7.02. Method of Asserting Claims. All claims for
indemnification by any Indemnified Party under Section 7.01 must be asserted and
resolved as follows:
(a) In the event any claim or demand in respect of which an
Indemnified Party might seek indemnity under Section 7.01 is asserted against or
sought to be collected from such Indemnified Party by a Person other than the
Warrantors or any of their respective Affiliates (a "THIRD PARTY CLAIM"), the
Indemnified Party shall deliver a Claim Notice with reasonable promptness to the
Indemnifying Party. The Indemnifying Party shall notify the Indemnified Party as
soon as practicable within the Dispute Period whether the Indemnifying Party
disputes its liability to the Indemnified Party under Section 7.01 and whether
the Indemnifying Party desires, at its sole cost and expense, to defend the
Indemnified Party against such Third Party Claim.
(i) If the Indemnifying Party notifies the Indemnified Party
within the Dispute Period that the Indemnifying Party desires to defend the
Indemnified Party with respect to the Third Party Claim pursuant to this Section
7.02(a), then the Indemnifying Party shall have the right to defend, at the sole
cost and expense of the Indemnifying Party, such Third Party Claim by all
appropriate proceedings, which proceedings shall be vigorously and diligently
prosecuted by the Indemnifying Party to a final conclusion or shall be settled
at the discretion of the Indemnifying Party (but only with the consent of the
Indemnified Party, which consent shall not be unreasonably withheld or delayed
in the case of any settlement that provides for any relief other than the
payment of monetary damages as to which the Indemnified Party shall be
indemnified in full). The Indemnifying Party shall have full control of such
defense and proceedings, including (except as provided in the immediately
preceding sentence) any settlement thereof, except that:
(x) the Indemnified Party may, at the sole cost and expense
of the Indemnified Party, at any time prior to the Indemnifying Party's delivery
of the notice referred to in the first sentence of this clause (i), file any
motion, answer or other pleadings or take any other action that the Indemnified
Party reasonably believes to be necessary or appropriate to protect its
interests and not prejudicial to the Indemnifying Party (it being understood and
agreed that, except as provided in clause (ii) below, if an Indemnified Party
takes any such action that is prejudicial and causes a final adjudication that
is adverse to the Indemnifying Party, the Indemnifying Party shall be relieved
of its obligations hereunder with respect to the portion of such Third Party
Claim prejudiced by the Indemnified Party's action); and
(y) if requested by the Indemnifying Party, the Indemnified
Party shall, at the sole cost and expense of the Indemnifying Party, cooperate
with the Indemnifying Party and its counsel in contesting any Third Party Claim
that the
24
Indemnifying Party elects to contest, or, if appropriate and related to the
Third Party Claim in question, in making any counterclaim against the Person
asserting the Third Party Claim, or any cross-complaint against any Person
(other than the Indemnified Party or any of its Affiliates).
The Indemnified Party may retain separate counsel to
represent it in, but not control, any defense or settlement of any Third Party
Claim controlled by the Indemnifying Party pursuant to this clause (i), and the
Indemnified Party shall bear its own costs and expenses with respect to such
separate counsel except as provided in the preceding sentence. Notwithstanding
the foregoing, the Indemnified Party may retain or take over the control of the
defense or settlement of any Third Party Claim the defense of which the
Indemnifying Party has elected to control if the Indemnified Party irrevocably
waives its right to indemnity under Section 7.01 with respect to such Third
Party Claim.
(ii) If the Indemnifying Party fails to notify the Indemnified
Party within the Dispute Period that the Indemnifying Party desires to defend
the Third Party Claim pursuant to this Section 7.02(a), then the Indemnified
Party shall have the right to defend, at the sole cost and expense of the
Indemnifying Party, the Third Party Claim by all appropriate proceedings, which
proceedings shall be vigorously and diligently prosecuted by the Indemnified
Party to a final conclusion or shall be settled at the discretion of the
Indemnified Party (with the consent of the Indemnifying Party, which consent
shall not be unreasonably withheld or delayed). The Indemnified Party shall have
full control of such defense and proceedings, including (except as provided in
the immediately preceding sentence) any settlement thereof; provided, however,
that:
(x) if requested by the Indemnified Party, the Indemnifying
Party shall, at the sole cost and expense of the Indemnifying Party, cooperate
with the Indemnified Party and its counsel in contesting any Third Party Claim
which the Indemnified Party is contesting, or, if appropriate and related to the
Third Party Claim in question, in making any counterclaim against the Person
asserting the Third Party Claim, or any cross-complaint against any Person
(other than the Indemnifying Party or any of its Affiliates);
(y) notwithstanding the foregoing provisions of this clause
(ii), if the Indemnifying Party has notified the Indemnified Party within the
Dispute Period that the Indemnifying Party disputes its liability hereunder to
the Indemnified Party with respect to such Third Party Claim and if such dispute
is resolved in favor of the Indemnifying Party in the manner provided in clause
(iii) below, the Indemnifying Party shall not be required to bear the costs and
expenses of the Indemnified Party's defense pursuant to this clause (ii) or of
the Indemnifying Party's participation therein at the Indemnified Party's
request, and the Indemnified Party shall reimburse the Indemnifying Party in
full for all reasonable costs and expenses incurred by the Indemnifying Party in
connection with such litigation; and
25
(z) the Indemnifying Party may retain separate counsel to
represent it in, but not control, any defense or settlement controlled by the
Indemnified Party pursuant to this clause (ii), and the Indemnifying Party shall
bear its own costs and expenses with respect to such participation.
(iii) If the Indemnifying Party notifies the Indemnified Party
that it does not dispute its liability to the Indemnified Party with respect to
the Third Party Claim under Section 7.01 or fails to notify the Indemnified
Party within the Dispute Period whether the Indemnifying Party disputes its
liability to the Indemnified Party with respect to such Third Party Claim, the
Loss arising from such Third Party Claim shall, subject to the provisions of
Section 7.01(c), be conclusively deemed a liability of the Indemnifying Party
under Section 7.01 and the Indemnifying Party shall, subject to the provisions
of Section 7.01(c), pay the amount of such Loss to the Indemnified Party on
demand following the final determination thereof. If the Indemnifying Party has
timely disputed its liability with respect to such claim, the Indemnifying Party
and the Indemnified Party shall proceed in good faith to negotiate a resolution
of such dispute and, if not resolved through negotiations, such dispute shall be
resolved in accordance with the dispute resolution provisions in Section 10.10.
(b) In the event of a claim by any Indemnified Party under Section
7.01 against any Indemnifying Party that does not involve a Third Party Claim,
the Indemnified Party shall deliver an Indemnity Notice with reasonable
promptness to the Indemnifying Party. If the Indemnifying Party notifies the
Indemnified Party that it does not dispute the claim described in such Indemnity
Notice or fails to notify the Indemnified Party within the Dispute Period
whether the Indemnifying Party disputes the claim described in such Indemnity
Notice, the Loss arising from the claim specified in such Indemnity Notice
shall, subject to the provisions of Section 7.01(c), be conclusively deemed a
liability of the Indemnifying Party under Section 7.01 and the Indemnifying
Party shall, subject to the provisions of Section 7.01(c), pay the amount of
such Loss to the Indemnified Party on demand following the final determination
thereof. If the Indemnifying Party has timely disputed its liability with
respect to such claim, the Indemnifying Party and the Indemnified Party shall
proceed in good faith to negotiate a resolution of such dispute, and if not
resolved through negotiations, such dispute shall be resolved in accordance with
the dispute resolution provisions in Section 10.10.
SECTION 7.03. Exclusivity. After the Closing, except in the event of
fraud or willful breach of representations, warranties or covenants herein, the
indemnities set forth in this Article VII shall be the sole and exclusive
remedies of each Investor and its respective officers, directors, employees,
agents and Affiliates for any breach of representation or warranty or
nonfulfillment of or failure to perform any covenant or agreement made in this
Agreement, and the parties shall not be entitled to a rescission of this
Agreement or to any further indemnification rights or claims of any nature
whatsoever in respect thereof, all of which the parties hereto hereby waive. No
Person who was an officer, director or stockholder of the Company or any of the
Subsidiaries prior to the Closing or any of their respective Affiliates shall
have any liability to make any payment in respect of any breach of any
representation or warranty
26
or non-performance of any covenant or agreement made in this Agreement, except
for the Company's indemnification obligations under this Article VII.
SECTION 7.04. No Consequential Damages. Anything herein to the
contrary notwithstanding, no party shall be liable under this Agreement or with
respect to the transactions contemplated hereby for any consequential,
exemplary, punitive, special, indirect or incidental damages, including loss of
profits or revenue or any multiple of damages.
SECTION 7.05. Limitation of Liability. No recourse shall be had for
any claim based on or otherwise in respect of this Agreement or the transactions
contemplated hereby against any Person other than the Warrantors or the
Investors.
ARTICLE VIII
TERMINATION
SECTION 8.01. Termination. This Agreement may be terminated, and the
transactions contemplated hereby may be abandoned:
(a) at any time before the Closing, by mutual written agreement of the
Company and the Investors; or
(b) after the Closing by the Lead Series B Investor in the event the
Conditions Subsequent shall have not been satisfied or waived by March 31, 2007;
SECTION 8.02. Effect of Termination. (a) Subject to paragraph (b)
below, if this Agreement is validly terminated pursuant to Section 8.01, this
Agreement shall forthwith become null and void, and there shall be no liability
or obligation on the part of the Company or any Investor (or any of their
respective officers, directors, employees, agents or other Representatives or
Affiliates) under this Agreement or in connection with the transactions
contemplated hereby, except that such termination shall not relieve any
breaching party from liability hereunder from willful breach of any
representation or warranty contained herein or any breach of any covenant or
agreement contained herein.
(b) If this Agreement is validly terminated pursuant to Section
8.01(b), within five (5) Business Days after receipt of such written request
from the Lead Series B Investor, the Escrow Agent shall (i) release the Escrow
Amount (together with any accrued interest paid thereon by the Escrow Agent) to
the bank accounts designated by the Lead Series B Investor in writing and (ii)
return the Escrow Share Certificates to the Company. Immediately upon the return
by the Escrow Agent of the Escrow Amount (together with any accrued interest
paid by the Escrow Agent) to each Investor, such Investor shall no longer be a
shareholder of the Company with respect to the Escrow Shares and shall not have
any rights, interests or claims with respect to the Company as a shareholder of
the Company with respect to the Escrow Shares.
27
ARTICLE IX
DEFINITIONS
SECTION 9.01. Defined Terms. As used in this Agreement, the following
defined terms have the meanings indicated below:
"ACTIONS OR PROCEEDINGS" means any action, suit, proceeding,
arbitration or Governmental or Regulatory Authority investigation.
"ACTUAL ANNUAL FINANCIAL STATEMENTS" has the meaning ascribed to it in
Section 2.09(a).
"ACTUAL INTERIM FINANCIAL STATEMENTS" has the meaning ascribed to it
in Section 2.09(a).
"ADVANCE PAYMENT" means, with respect to each Advance Payment
Investor, such amount of advance payment made by such Advance Payment Investor
to the Company pursuant to the Advance Payment Agreement between such Advance
Payment Investor and the Company, to the extent that such advance payment equals
the purchase price of the Series B Preferred Shares allocated by the Company to
such Advance Payment Investor as indicated as the Purchase Price set forth
opposite such Advance Payment Investor's name on Schedule 1.
"ADVANCE PAYMENT INVESTORS" means Modern Peakview Limited, KWR
International Ltd., and DBS Nominees (Private) Limited.
"ADVANCE PAYMENT SHARES" has the meaning ascribed to it in Section
1.04(c).
"ADVANCE PAYMENT SHARE CERTIFICATES" has the meaning ascribed to it in
Section 1.04(c).
"AFFILIATE" means any Person that directly, or indirectly through one
or more intermediaries, controls or is controlled by or is under common control
with the Person specified. For purposes of this definition, control of a Person
means the power, direct or indirect, to direct or cause the direction of the
management and policies of such Person whether by Contract or otherwise and, in
any event and without limitation of the previous sentence, any Person owning
fifty percent (50%) or more of the voting securities of another Person shall be
deemed to control that Person.
"AGREEMENT" means this Series B Preferred Share Purchase Agreement,
the Disclosure Schedule, the exhibits and annexes attached hereto.
"AMENDED ARTICLES" means the Second Amended and Restated Memorandum
and Articles of Association of the Company.
28
"ASSETS AND PROPERTIES" of any Person means all assets and properties
of every kind, nature, character and description (whether real, personal or
mixed, whether tangible or intangible, and wherever situated), including the
goodwill related thereto, operated, owned or leased by such Person.
"BOOKS AND RECORDS" means all files, documents, instruments, papers,
books and records relating to the Business or Condition of the Company,
including without limitation financial statements, Tax returns and related work
papers and letters from accountants, budgets, pricing guidelines, ledgers,
journals, deeds, title policies, minute books, stock certificates and books,
stock transfer ledgers, Contracts, Licenses, operating data and plans.
"BUSINESS" means the design, manufacture, sales, assembly,
installation and servicing of photovoltaic products engaged in by the Company,
directly or indirectly through the Subsidiaries.
"BUSINESS DAY" means a day other than Saturday, Sunday or any day on
which banks located in Hong Kong are authorized or obligated to close.
"BUSINESS OR CONDITION OF THE COMPANY" means the business, financial
condition or results of operations of the Company and the Subsidiaries taken as
a whole.
"CLAIM NOTICE" means written notification pursuant to Section 7.02(a)
of a Third Party Claim as to which indemnity under Section 7.01 is sought by an
Indemnified Party, enclosing a copy of all papers served, if any, and specifying
the nature of and basis for such Third Party Claim and for the Indemnified
Party's claim against the Indemnifying Party under Section 7.01, together with
the amount or, if not then reasonably determinable, the estimated amount,
determined in good faith, of the Loss arising from such Third Party Claim.
"CLOSING" means the closing of the transactions contemplated by
Article I.
"CLOSING DATE" has the meaning ascribed to it in Section 1.02.
"COMPANY" has the meaning ascribed to it in the preamble of this
Agreement.
"COMPANY INTELLECTUAL PROPERTY" has the meaning ascribed to it in
Section 2.16.
"CONDITIONS SUBSEQUENT" has the meaning ascribed to it in Section
1.06(c).
"CONTRACT" means any agreement, lease, license, evidence of
Indebtedness, mortgage, indenture, security agreement or other contract.
29
"DISCLOSURE SCHEDULE" means the records delivered to the Investors on
behalf of the Company herewith and dated as of the date hereof, containing all
lists, exceptions and other information and materials as may be provided or deem
to be provided pursuant to this Agreement.
"DISPUTE PERIOD" means the period ending twenty (20) days following
receipt by an Indemnifying Party of either a Claim Notice or an Indemnity
Notice.
"ENVIRONMENTAL PERMITS" has the meaning ascribed to it in Section
2.20(c).
"ENVIRONMENTAL LAWS" means all Laws of any jurisdiction in which the
Company or any Subsidiary conducts business or operations relating to pollution
and the environment generally.
"ESCROW AGENT" has the meaning ascribed to it in Section 1.06(a).
"ESCROW AGREEMENT" has the meaning ascribed to it in Section 1.06(a).
"ESCROW AMOUNT" has the meaning ascribed to it in Section 1.03(b).
"ESCROW SHARES" has the meaning ascribed to it in Section 1.04(b).
"ESCROW SHARE CERTIFICATES" has the meaning ascribed to it in Section
1.04(b).
"FINANCIAL STATEMENTS" means the drafts of the unaudited consolidated
balance sheets, income statements and statements of cash flow of Tianwei Yingli
for the years ended on December 31, 2004 and 2005 and for the six months ended
June 30, 2006, in each case, prepared in accordance with US GAAP and included in
the Disclosure Schedule.
"FOUNDER" has the meaning ascribed to it in the Preamble.
"GOVERNMENTAL OR REGULATORY AUTHORITY" means any applicable court,
tribunal, arbitrator, authority, agency, commission, official or other
instrumentality of any jurisdiction in which a Person conducts business or
operations.
"HOLDCO" has the meaning ascribed to it in the Preamble.
"ICC" has the meaning ascribed to it in Section 10.10(b).
"INDEBTEDNESS" of any Person means all obligations of such Person (i)
for borrowed money, (ii) evidenced by notes, bonds, debentures or similar
instruments, (iii)
30
under capital leases and (iv) in the nature of guarantees of the obligations
described in clauses (i) through (iii) above of any other Person.
"INDEMNIFIED PARTY" means any Person claiming indemnification under
any provision of Article VII.
"INDEMNIFYING PARTY" means any Person against whom a claim for
indemnification is being asserted under any provision of Article VII.
"INDEMNITY NOTICE" means written notification pursuant to Section
7.02(b) of a claim for indemnity under Article VII, specifying the nature of and
basis for such claim, together with the amount or, if not then reasonably
determinable, the estimated amount, determined in good faith, of the Loss
arising from such claim.
"INTELLECTUAL PROPERTY" of any Person means all patents and patent
rights, trademarks and trademark rights, trade names and trade name rights,
service marks and service ▇▇▇▇ rights, service names and service name rights,
brand names, domain names, inventions, copyrights and copyright rights, know-how
and all pending applications for and registrations of patents, trademarks,
service marks and copyrights.
"INVESTMENT ASSETS" of any Person means all debentures, notes and
other evidences of Indebtedness, stocks, securities (including rights to
purchase and securities convertible into or exchangeable for other securities),
interests in joint ventures and general and limited partnerships, mortgage loans
and other investment or portfolio assets owned of record or beneficially by such
Person (other than trade receivables generated in the ordinary course of
business of such Person).
"INVESTOR" has the meaning ascribed to it in the preamble of this
Agreement.
"JOINT VENTURE CONTRACT" has the meaning ascribed to it in Section
1.05(c) of this Agreement.
"JV ARTICLE AMENDMENT" has the meaning ascribed to it in Section
1.06(c) of this Agreement.
"JV CONTRACT AMENDMENT" has the meaning ascribed to it in Section
1.06(c) of this Agreement.
"KNOWLEDGE" means, with respect to any matter in question, a party's
actual knowledge after due and diligent inquiries of officers, directors and
other employees of such party reasonably believed to have knowledge of the
matter in question. Any such individual will be deemed to have Knowledge of a
particular fact, circumstance, event or other matter if (i) such individual has
actual knowledge of such fact, circumstance, event or other matter; or (ii) such
fact, circumstance, event or other
31
matter is reflected in one or more documents in, or that have been in, such
individual's possession, including personal files of such person.
"LAWS" means, with respect to a Person, all laws, statutes, rules,
regulations, ordinances and other pronouncements having the effect of law of any
jurisdiction in which such Person conducts business or operations or of any
Governmental or Regulatory Authority.
"LEAD SERIES B SHAREHOLDER" has the meaning ascribed to it in the
Shareholders Agreement.
"LIABILITIES" means all Indebtedness, obligations and other
liabilities of a Person (whether absolute, accrued, contingent, fixed or
otherwise, or whether due or to become due).
"LICENSES" means all licenses, permits, certificates of authority,
authorizations, approvals, registrations, franchises and similar consents
granted or issued by any Governmental or Regulatory Authority.
"LIENS" means any mortgage, pledge, assessment, security interest,
lease, lien, levy, charge or other encumbrance of any kind, or any conditional
sale Contract, title retention Contract or other Contract to give any of the
foregoing.
"LOSS" means any and all damages, fines, penalties, deficiencies,
losses and expenses (including without limitation interest, court costs,
reasonable fees of attorneys, accountants and other experts or other reasonable
expenses of litigation or other proceedings or of any claim, default or
assessment).
"M&A REGULATIONS" means the Regulations on Acquisition of Domestic
Enterprises by Foreign Investors promulgated by the Ministry of Commerce and
other Governmental or Regulatory Authorities of the PRC on August 8, 2006 and
effective as of September 8, 2006.
"MATERIAL ADVERSE EFFECT" means an effect of any change, circumstance,
condition, development, effect, event, occurrence or state of facts that,
individually or in the aggregate, is or has been, or would reasonably be
expected to be, materially adverse to the Business or Condition of the Company,
other than an effect of any change, circumstance, condition, development,
effect, event, occurrence or state of facts relating to (i) economic or industry
conditions generally, (ii) any change in Laws or regulatory conditions directly
and specifically affecting any segment of the energy industry, (iii) any change
in political conditions, including any acts of war or terrorist activities,
directly affecting any segment of the energy industry, (iii) any change in US
GAAP, or (iv) any adverse change, effect, event, occurrence, state of facts or
development arising from or relating to compliance with the terms of this
Agreement, or action taken, or failed to be taken, to which the Investors have
consented in writing.
32
"MATERIAL CONTRACT" has the meaning ascribed to it in Section 2.17.
"OPTION" with respect to any Person means any security, right,
subscription, warrant, option, "phantom" stock right or other Contract that
gives the right to (i) purchase or otherwise receive or be issued any shares of
capital stock of such Person or any security of any kind convertible into or
exchangeable or exercisable for any shares of capital stock of such Person or
(ii) receive or exercise any benefits or rights similar to any rights enjoyed by
or accruing to the holder of shares of capital stock of such Person, including
any rights to participate in the equity or income of such Person or to
participate in or direct the election of any directors or officers of such
Person or the manner in which any shares of capital stock of such Person are
voted.
"ORDER" means any writ, judgment, decree, injunction or similar order
of any Governmental or Regulatory Authority (in each such case whether
preliminary or final).
"ORDINARY SHARES" has the meaning ascribed to it in Section 2.04.
"PERMITTED LIEN" means (i) statutory Liens for current Taxes not yet
due and payable or Taxes being contested in good faith through appropriate
proceedings, (ii) mechanics', carriers', workers', repairers' and other similar
Liens imposed by Law arising or incurred in the ordinary course of business for
obligations not yet due, (iii) in the case of leases of vehicles and other
personal property, Liens which do not, individually or in the aggregate,
materially impair the use of such leased equipment or other personal property,
(iv) Liens incidental to the operation of the Business or the ownership by the
Company or any Subsidiary of any of their Assets and Properties which were not
incurred in connection with the borrowing of money or the advance of credit and
which do not materially detract from the value of the assets encumbered thereby
or materially interfere with the use thereof, (v) in the case of Licenses or
other rights to use the Company Intellectual Property, Liens or other
restrictions arising from the terms thereof, and (vi) Liens on leases of real
property arising from the provisions of such leases, including, in relation to
leased real property, any agreements and/or conditions imposed by Laws on the
issuance of land use permits, zoning, business licenses, use permits or other
entitlements of various types issued by any Governmental or Regulatory
Authority, necessary or beneficial to the continued use and occupancy of the
Assets and Properties of the Company or any Subsidiary.
"PERSON" means any natural person, corporation, limited liability
company, general partnership, limited partnership, proprietorship, other
business organization, trust, union, association or Governmental or Regulatory
Authority.
"PRO RATA EXPENSE" means, with respect to each Investor other than the
Lead Series B Shareholder, the proportionate amount of costs and expenses
incurred by the Lead Series B Shareholder, which is borne by such Investor
pursuant to Section 10.03 hereof, which amount will be set forth in a written
notice provided by the Lead Series B
33
Shareholder to such Investor and the Company at least three (3) Business Days
prior to the Closing.
"PROCEEDS" has the meaning ascribed to it in Section 1.05.
"PRC" means the People's Republic of China and, for the purpose of
this Agreement, excluding Hong Kong Special Administrative Region, Macau Special
Administrative Region and Taiwan.
"PURCHASE PRICE" has the meaning ascribed to it in Section 1.03.
"QUALIFIED IPO" has the meaning ascribed to it in the Shareholders
Agreement.
"RELEASED AMOUNT" has the meaning ascribed to it in Section 1.03(a)
hereof.
"RELEASED SHARES" has the meaning ascribed to it in Section 1.04(a).
"RELEASED SHARE CERTIFICATES" has the meaning ascribed to it in
Section 1.04(a).
"REPRESENTATIVES" means, with respect to any Person, such Person's
counsel, accountants, financial advisors, consultants and other representatives.
"SAFE CIRCULAR 75" means the Circular on Issues Relating to Foreign
Exchange Administration of Financings and Return Investments by Onshore
Residents Utilizing Offshore Special Purpose Companies (Hui Fa (2005) No. 75)
issued by the State Administration of Foreign Exchange of the PRC on October 21,
2005.
"SECURITIES ACT" has the meaning ascribed to it in Section 2.23.
"SERIES B PREFERRED SHARES" has the meaning ascribed to it in the
preamble of this Agreement.
"SHARES" has the meaning ascribed to it in Section 1.01.
"SHARE CERTIFICATES" means, collectively, the Released Share
Certificates, the Escrow Share Certificates and the Advance Payment Share
Certificates.
"SHAREHOLDER LOAN" has the meaning ascribed to it in Section 1.05.
"SHAREHOLDERS AGREEMENT" means the Amended and Restated Shareholders
Agreement substantially in the form attached hereto as Exhibit B.
34
"SUBSIDIARY" means any Person (i) in which the Company, directly or
indirectly, beneficially owns more than fifty percent (50%) of either the equity
interests in, or the voting control of, such Person, including without
limitation Tianwei Yingli or (ii) any Person with respect to which the Company
has the power to otherwise direct the business and policies of such Person
directly or indirectly through another subsidiary.
"TAXES" means any taxes, charges, fees, levies, other assessments, or
withholding taxes or charges imposed by any Governmental or Regulatory
Authority, and includes any interest and penalties on or additions to any such
Taxes and any expenses incurred in connection with the determination, settlement
or litigation of any Tax Liabilities.
"THIRD PARTY CLAIM" has the meaning ascribed to it in Section 7.02(a).
"TIANWEI YINGLI" means Baoding Tianwei Yingli New Energy Resources
Co., Ltd., a Sino-foreign equity joint venture with limited liability registered
and existing under the laws of the PRC.
"TRANSACTION DOCUMENTS" means this Agreement and each of the
agreements and documents set forth in Exhibit A attached hereto.
"U.S. DOLLARS" or "US$" means the lawful currency of the United States
of America.
"US GAAP" means generally accepted accounting principles in the United
States, consistently applied throughout the specified period and in the
immediately prior comparable period.
"WARRANT" has the meaning ascribed to it in the Warrant Side Letter.
"WARRANT SHARES" has the meaning ascribed to it in the Warrant Side
Letter.
"WARRANT SIDE LETTER" has the meaning ascribed to it in Section
5.02(k) hereof.
"WARRANTORS" has the meaning ascribed to it in the preamble of Article
II hereof.
SECTION 9.02. Construction of Certain Terms and Phrases. Unless the
context of this Agreement otherwise requires, (i) words of any gender include
each other gender; (ii) words using the singular or plural number also include
the plural or singular number, respectively; (iii) the terms "hereof," "herein,"
"hereby," "hereunder" and derivative or similar words refer to this entire
Agreement; (iv) the terms "Article" or "Section" refer to the specified Article
or Section of this Agreement; and (v) the phrase "ordinary course of business"
refers to the business of the Company consistent with past
35
custom and practice. Whenever this Agreement refers to a number of days, such
number shall refer to calendar days unless Business Days are specified. All
accounting terms used herein and not expressly defined herein shall have the
meanings given to them under US GAAP. Any representation or warranty contained
herein as to the enforceability of a Contract (including this Agreement) shall
be subject to the effect of any bankruptcy, insolvency, reorganization,
moratorium or other similar Law affecting the enforcement of creditors' rights
generally and to general equitable principles (regardless of whether such
enforceability is considered in a proceeding in equity or at law).
ARTICLE X
MISCELLANEOUS
SECTION 10.01. Notices. All notices, requests and other communications
hereunder must be in writing and shall be deemed to have been duly given only if
delivered personally or by facsimile transmission or mailed (first class postage
prepaid) to the parties at the following addresses or facsimile numbers:
If to the Investors, to the address of each Investor set forth under
such Investor's name on Schedule I attached hereto.
If to the Company, to:
Yingli Green Energy Holding Company Limited
No. 3055 Middle Fuxing Road
Baoding, People's Republic of China
Facsimile No.: ▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇
Attn: Conghui Liu.
All such notices, requests and other communications shall (a) if delivered
personally to the address as provided in this Section, be deemed given upon
delivery, (b) if delivered by facsimile transmission to the facsimile number as
provided in this Section, be deemed given upon receipt, and (c) if delivered by
mail in the manner described above to the address as provided in this Section,
be deemed given upon receipt (in each case regardless of whether such notice,
request or other communication is received by any other Person to whom a copy of
such notice, request or other communication is to be delivered pursuant to this
Section). Any party from time to time may change its address, facsimile number
or other information for the purpose of notices to that party by giving notice
specifying such change to the other party hereto.
SECTION 10.02. Entire Agreement. This Agreement (including the
Disclosure Schedule, the exhibits and annexes attached hereto) supersedes all
prior discussions and agreements between the parties with respect to the subject
matter hereof, including the Series B Purchase Agreement, dated December 5,
2006, by and among the Company, Yingli Green Energy Holding Company Limited,
▇▇▇▇▇▇▇▇▇ ▇▇▇▇ and the
36
investors listed on Schedule I attached thereto, and contains the sole and
entire agreement between the parties hereto with respect to the subject matter
hereof.
SECTION 10.03. Expenses. Except as otherwise expressly provided in
this Agreement, whether or not the transactions contemplated hereby are
consummated, each party shall pay its own costs and expenses incurred in
connection with the negotiation, execution and closing of this Agreement and the
transactions contemplated hereby and thereby; provided, however, that such costs
and expenses incurred by the Lead Series B Shareholder shall be borne
proportionately among all of the Investors.
SECTION 10.04. Public Announcements. At all times at or before the
Closing, neither the Company nor any Investor shall issue or make any reports,
statements or releases to the public with respect to this Agreement or the
transactions contemplated hereby without the consent of the other, which consent
shall not be unreasonably withheld or delayed. If either party is unable to
obtain the approval of its public report, statement or release from the other
party and such report, statement or release is, in the opinion of legal counsel
to such party, required by Law in order to discharge such party's disclosure
obligations, then such party may make or issue the legally required report,
statement or release and promptly furnish the other party with a copy thereof.
The Company and each Investor shall also obtain prior approval by the other
parties of any public announcement, including without limitation any press
release, interviews with media and attendance in any press conference or related
forums, to be made immediately following the Closing announcing the consummation
of the transactions contemplated by this Agreement.
SECTION 10.05. Amendment and Waiver. This Agreement may be amended and
the observance of any term of this Agreement may be waived (either generally or
in a particular instance and either retroactively or prospectively), only with
the written consent of the Company and the Lead Series B Shareholder. Any
amendment or waiver effected in accordance with this section shall be binding
upon each holder of any securities purchased in this Agreement at the time
outstanding (including securities into which such securities are convertible),
each future holder of all such securities, and the Company.
SECTION 10.06. No Third Party Beneficiary. The terms and provisions of
this Agreement are intended solely for the benefit of each party hereto and
their respective successors or permitted assigns, and it is not the intention of
the parties to confer third party beneficiary rights upon any other Person.
SECTION 10.07. No Assignment; Binding Effect. Neither this Agreement
nor any right, interest or obligation hereunder may be assigned by any party
hereto without the prior written consent of the other party hereto and any
attempt to do so shall be void, except that each Investor may assign any or all
of its rights, interests and obligations hereunder to its Affiliates, provided
that any such Affiliate agrees in writing to be bound by all of the terms,
conditions and provisions contained herein, but no such
37
assignment shall relieve such Investor of its obligations hereunder. Subject to
the preceding sentence, this Agreement is binding upon, inures to the benefit of
and is enforceable by the parties hereto and their respective successors and
permitted assigns.
SECTION 10.08. Enforcement of Agreement. Notwithstanding anything to
the contrary in this Agreement, the parties hereto agree that irreparable damage
for which monetary damages, even if available, would not be an adequate remedy
would occur in the event that any of the provisions of this Agreement (including
the failure by any party to take such actions as are required of it hereunder to
consummate this Agreement) was not performed in accordance with its specified
terms or was otherwise breached. It is accordingly agreed that the parties shall
be entitled to an injunction or other equitable relief to prevent breaches of
this Agreement and to enforce specifically the terms and provisions hereof in
any court of competent jurisdiction, this being in addition to any other remedy
to which they are entitled at law or in equity.
SECTION 10.09. Headings. The headings used in this Agreement have been
inserted for convenience of reference only and do not define or limit the
provisions hereof.
SECTION 10.10. Governing Law; Dispute Resolution.
(a) This Agreement shall be governed by and construed in accordance
with the laws of the State of New York applicable to a contract executed and
performed in such jurisdiction, without giving effect to the conflicts of laws
principles thereof.
(b) Any controversy or claim arising out of or relating to this
Agreement, or any breach of this Agreement, shall be initiated, maintained and
finally determined by binding arbitration under the rules of conciliation and
arbitration of the International Chamber of Commerce (the "ICC"); and the site
of the arbitration, unless the parties agree otherwise, shall be in Hong Kong.
The arbitral tribunal shall be appointed within thirty (30) days of the notice
of dispute, and shall consist of three arbitrators, one of which shall be
appointed by the Investors and one by the Company and the third by the Investors
and the Company jointly; provided, however, that if the Investors and the
Company shall be unable to select the third arbitrator within such thirty
(30)-day period, such third arbitrator shall be chosen by the International
Court of Arbitration of the ICC. Judgment upon any award rendered may be entered
in any court having jurisdiction thereof, or application may be made to such
court for a judicial acceptance of the award and an order of enforcement, as the
case may be. Any award pursuant to such proceeding shall be granted in U.S.
Dollars. The fees and costs of the arbitration shall be shared equally by all
disputing parties. The arbitrators shall award legal fees, disbursements and
other expenses to the prevailing party for such amounts as determined by the
arbitrators to be appropriate.
SECTION 10.11. Invalid Provisions. If any provision of this Agreement
is held to be illegal, invalid or unenforceable under any present or future Law,
and if the rights or obligations of any party hereto under this Agreement shall
not be materially and adversely affected thereby, (a) such provision shall be
fully severable,
38
(b) this Agreement shall be construed and enforced as if such illegal, invalid
or unenforceable provision had never comprised a part hereof, and (c) the
remaining provisions of this Agreement shall remain in full force and effect and
shall not be affected by the illegal, invalid or unenforceable provision or by
its severance herefrom.
SECTION 10.12. Counterparts. This Agreement may be executed in any
number of counterparts, each of which shall be deemed an original, but all of
which together shall constitute one and the same instrument. A facsimile,
telecopy or other reproduction of this Agreement may be executed by one or more
parties hereto and delivered by such party by facsimile or any similar
electronic transmission device pursuant to which the signature of or on behalf
of such party can be seen. Such execution and delivery shall be considered
valid, binding and effective for all purposes. At the request of any party
hereto, all parties hereto agree to execute and deliver an original of this
Agreement as well as any facsimile, telecopy or other reproduction hereof.
[Signature pages follow]
39
IN WITNESS WHEREOF, this Agreement has been duly executed and
delivered by or on behalf of each party hereto as of the date first above
written.
YINGLI GREEN ENERGY HOLDING COMPANY
LIMITED
By: /s/ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇
------------------------------------
Name: ▇▇▇▇▇▇▇▇▇ ▇▇▇▇
Title: Chairman and Chief Executive
Officer
YINGLI POWER HOLDING COMPANY LTD.
By: /s/ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇
------------------------------------
Name: ▇▇▇▇▇▇▇▇▇ ▇▇▇▇
Title: Director
/s/ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇
----------------------------------------
▇▇▇▇▇▇▇▇▇ ▇▇▇▇
BAYTREE INVESTMENTS (MAURITIUS) PTE LTD.
By: /s/ ▇▇▇▇▇▇▇ ▇▇▇▇
------------------------------------
Name: ▇▇▇▇▇▇▇ ▇▇▇▇
Title: Director
CREATION WAY ASSET MANAGEMENT LTD.
By: /s/ ▇▇▇▇▇ ▇▇▇
------------------------------------
Name: ▇▇▇▇▇ ▇▇▇
Title: Director
INCEI, S.A.
By: /s/ ▇▇▇ ▇▇▇▇▇ ▇▇ ▇▇▇
------------------------------------
Name: ▇▇▇ ▇▇▇▇▇ Fu Lee
Title: Chairman
▇.▇. ▇▇▇▇▇▇ SECURITIES LTD.
By: /s/ ▇▇▇▇. ▇. ▇▇▇▇▇▇▇▇▇
------------------------------------
Name: ▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
Title: Managing Director
For and on behalf of ▇.▇. ▇▇▇▇▇▇
Securities (Asia Pacific) Limited as
agent for ▇.▇. ▇▇▇▇▇▇ Securities Ltd.
BENCHMARK EUROPE II, L.P.
as nominee for
Benchmark Europe II, L.P.
Benchmark Europe Founders' Fund II, L.P.
and related individuals
By: Benchmark Management (UK) LLP
its manager
By: /s/ ▇▇▇▇ ▇▇▇▇▇▇
------------------------------------
Member
TB HOLDINGS LTD.
By: /s/ ▇▇▇▇▇▇ ▇▇
------------------------------------
Name: ▇▇▇▇▇▇ ▇▇
Title: Director
NEW HORIZON KEENSOLAR INVESTMENT CO.,
LTD.
By: /s/ ▇▇▇▇▇▇▇▇ ▇▇
------------------------------------
Name: ▇▇▇▇▇▇▇▇ ▇▇
Title: Managing Partner
▇▇▇▇ INVESTMENTS LLC
By: /s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇
------------------------------------
Name: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇
Title: President
DBS NOMINEES (PRIVATE) LIMITED
By: /s/ ▇▇▇▇▇▇ ▇▇▇ Tzai Win
------------------------------------
Name: ▇▇▇▇▇▇ ▇▇▇ Tzai Win
Title: Managing Director
KWR INTERNATIONAL LTD.
By: /s/ ▇▇▇▇▇▇ ▇▇▇▇
------------------------------------
Name: ▇▇▇▇▇▇ ▇▇▇▇
Title: Director
MODERN PEAKVIEW LIMITED
By: /s/ ▇▇▇ ▇▇▇
------------------------------------
Name: ▇▇▇ ▇▇▇
Title: Authorized Signatory
DAEDALUS HOLDINGS, L.L.C.
By: Farallon Capital Management, L.L.C.,
its manager
By: /s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇
------------------------------------
Name: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇
Title: Managing Member
PCM DIRECT CAPITAL FUND
By: /s/ ▇▇▇▇▇▇ ▇▇
------------------------------------
Name: ▇▇▇▇▇▇ ▇▇
Title: Director
THE TRUSTEES OF COLUMBIA UNIVERSITY
IN THE CITY OF NEW YORK
By: /s/ ▇▇ ▇▇▇▇▇▇▇▇
------------------------------------
Name: ▇▇ ▇▇▇▇▇▇▇▇
Title: President and CEO, Columbia
Investment Management Co., LLC
SCHEDULE I
SCHEDULE OF THE INVESTORS
NUMBER OF NUMBER OF
SHARES NUMBER OF NUMBER OF ADVANCE PURCHASE RELEASED ESCROW
BEING RELEASED ESCROW PAYMENT PRICE AMOUNT AMOUNT
INVESTOR ADDRESS PURCHASED SHARES SHARES SHARES (US$) (US$) (US$)
-------- ---------------------------- ---------- ---------- --------- --------- ------------ ----------- -----------
Baytree ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇, 9,307,135 7,445,708 1,861,427 -- $ 45,000,000 $36,000,000 $ 9,000,000
Investments #06-18 Tower 2,
(Mauritius) Pte The Atrium@Orchard,
Ltd. ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇
Fax No.: ▇▇▇ ▇▇▇▇ ▇▇▇▇
Attention: ▇▇▇▇▇▇▇ ▇▇▇▇,
▇▇▇▇▇▇ ▇▇▇▇▇▇ and ▇▇▇▇ ▇▇
Creation Way Portcullis Trustnet ▇▇▇▇▇▇▇▇ 2,068,252 1,654,602 413,650 -- $ 10,000,000 $ 8,000,000 $ 2,000,000
Asset Road Town, Tortola, British
Management Ltd. Virgin Island
Fax No.: ▇▇▇-▇▇▇▇ ▇▇▇▇
Attention: ▇▇▇▇▇ ▇▇▇
INCEI, S.A. Plaza ▇▇▇▇▇ y Cajal, 1-bajo 2,068,252 1,654,602 413,650 -- $ 10,000,000 $ 8,000,000 $ 2,000,000
▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇,
▇▇▇▇▇
Fax No.:
Attention:
▇.▇. ▇▇▇▇▇▇ 125 London Wall, 1,654,602 1,323,682 330,920 -- $ 8,000,000 $ 6,400,000 $ 1,600,000
Securities Ltd. ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇
▇▇▇▇▇▇ ▇▇▇▇▇▇▇
Attention: c/o ▇▇▇▇▇▇ ▇
▇▇▇▇▇▇ ▇▇/▇ ▇▇▇▇▇▇ ▇▇▇▇▇
▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇
▇▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇
Fax No.: ▇▇▇▇ ▇▇▇▇ ▇▇▇▇
NUMBER OF NUMBER OF
SHARES NUMBER OF NUMBER OF ADVANCE PURCHASE RELEASED ESCROW
BEING RELEASED ESCROW PAYMENT PRICE AMOUNT AMOUNT
INVESTOR ADDRESS PURCHASED SHARES SHARES SHARES (US$) (US$) (US$)
-------- ---------------------------- ---------- ---------- --------- --------- ------------ ----------- -----------
Benchmark ▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇ 1,551,189 1,240,951 310,238 -- $ 7,500,000 $ 6,000,000 $ 1,500,000
Europe II., ▇.▇. ▇▇▇ ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇
as nominee for Fax No: ▇▇▇(▇)▇▇ ▇▇▇▇ ▇▇▇▇
Benchmark Attention: ▇▇▇▇▇▇ ▇▇▇▇▇ /
Europe II, L.P., ▇▇▇▇ ▇▇▇▇▇▇
Benchmark
Europe Founders'
Fund II, L.P.
and related
individuals
▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇. ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇,▇▇▇▇ 1,137,539 910,031 227,508 -- $ 5,500,000 $ 4,400,000 $ 1,100,000
Lujiazui ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇
▇.▇.▇▇▇▇▇ ▇▇▇▇▇▇
Fax No.: ▇▇▇ ▇▇ ▇▇▇▇ ▇▇▇▇
Attention: ▇▇▇▇▇▇ ▇▇ and
▇▇▇▇▇▇▇ ▇▇▇▇
The Trustees of ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇. 1,034,126 827,301 206,825 -- $ 5,000,000 $ 4,000,000 $ 1,000,000
Columbia ▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇,
▇▇▇▇▇▇▇▇▇▇ ▇▇ ▇▇ ▇▇▇▇▇
the City of New Fax No.:
York Attention:
New Horizon ▇▇▇ ▇▇▇ Tower 1204, 89 Jin 1,034,126 827,301 206,825 -- $ 5,000,000 $ 4,000,000 $ 1,000,000
Keensolar Bao Street, Dongcheng
Investment Co., District, Beijing
Ltd China 100005
Fax No.: ▇▇▇ ▇▇-▇▇▇▇-▇▇▇▇
Attention: Kawada Hanae
NUMBER OF NUMBER OF
SHARES NUMBER OF NUMBER OF ADVANCE PURCHASE RELEASED ESCROW
BEING RELEASED ESCROW PAYMENT PRICE AMOUNT AMOUNT
INVESTOR ADDRESS PURCHASED SHARES SHARES SHARES (US$) (US$) (US$)
-------- ---------------------------- ---------- ---------- --------- --------- ------------ ----------- -----------
▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, 206,825 165,460 41,365 -- $ 1,000,000 $ 800,000 $ 200,000
Investments LLC ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
▇▇▇
Fax No.: ▇▇-▇▇▇-▇▇▇-▇▇▇▇
Attention: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇,
President
Daedalus c/o Farallon Capital 103,413 82,730 20,683 -- $ 500,000 $ 400,000 $ 100,000
Holdings, L.L.C. Management, L.L.C.
▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇,
▇▇▇▇▇ ▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇,
▇▇ ▇▇▇▇▇
Fax: (▇▇▇) ▇▇▇-▇▇▇▇
Attn: ▇▇▇▇ ▇▇▇▇
Copy to: ▇▇▇▇ ▇▇▇
PCM Direct c/o Prime Capital Management 103,413 82,730 20,683 -- $ 500,000 $ 400,000 $ 100,000
Capital Fund Company Limited
▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇▇,
▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇,
▇▇▇ ▇▇▇▇▇'▇ ▇▇▇▇ ▇▇▇▇▇▇▇,
▇▇▇▇ ▇▇▇▇
Fax Number: ▇▇▇-▇▇▇▇-▇▇▇▇
Attention: Director
DBS Nominees ▇ ▇▇▇▇▇▇▇ ▇▇▇, 2,481,903 -- -- 2,481,903 $ 12,000,000 -- --
(Private) DBS ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇,
▇▇▇▇▇▇▇ #▇▇-▇▇, ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇
Fax No.: (▇▇) ▇▇▇▇-▇▇▇▇
Attention: ▇▇▇▇▇▇ ▇▇▇ Tzai
Win, Managing Director
KWR ▇.▇. ▇▇▇ ▇▇▇▇, 1,137,539 -- -- 1,137,539 $ 5,500,000 -- --
International Offshore Incorporations
Ltd. Centre, Victoria, Mahe,
Seychelles.
Fax No.: ▇▇▇▇-▇▇▇▇-▇▇▇▇
Attention: ▇▇▇▇ ▇▇▇▇▇▇
NUMBER OF NUMBER OF
SHARES NUMBER OF NUMBER OF ADVANCE PURCHASE RELEASED ESCROW
BEING RELEASED ESCROW PAYMENT PRICE AMOUNT AMOUNT
INVESTOR ADDRESS PURCHASED SHARES SHARES SHARES (US$) (US$) (US$)
-------- ---------------------------- ---------- ---------- --------- --------- ------------ ----------- -----------
Modern Peakview Palm Grove House, 517,063 -- -- 517,063 $ 2,500,000 -- --
Limited ▇.▇. ▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇,
▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇
▇▇▇▇▇▇ ▇▇▇▇▇▇▇
Fax No.: ▇▇▇-▇▇-▇▇▇▇-▇▇▇▇
Attention: ▇▇▇ ▇▇▇
---------- ---------- --------- --------- ------------ ----------- -----------
TOTAL: 24,405,377 16,215,098 4,053,774 4,136,505 $118,000,000 $78,400,000 $19,600,000
========== ========== ========= ========= ============ =========== ===========
SCHEDULE II
DISCLOSURE SCHEDULE
[SEPARATELY PROVIDED]
EXHIBIT A
LIST OF TRANSACTION DOCUMENTS
This Agreement
The Shareholders Agreement
The Amended Articles
The Escrow Agreement
The JV Contract Amendment
The JV Article Amendment
The Warrant Side Letter
The Warrants
EXHIBIT B
SECOND AMENDED AND RESTATED SHAREHOLDERS AGREEMENT
[SEPARATELY PROVIDED]
EXHIBIT C
SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
[SEPARATELY PROVIDED]
EXHIBIT D
WARRANT SIDE LETTER
[SEPARATELY PROVIDED]
EXHIBIT E
ADDITIONAL INVESTOR REPRESENTATIONS AND WARRANTIES
1. The Investor understands that the Shares have not been registered under the
Securities Act and may only be sold or otherwise transferred in accordance
with the restrictions and conditions set forth in this Agreement and the
Shareholders Agreement.
2. The Investor understands that purchasing the Shares (the "TRANSACTION")
involves a high degree of risk and that the Shares are a speculative
investment.
3. The Investor (a) has consulted with its own legal, regulatory, tax,
business, investment, financial and accounting advisers in connection
herewith to the extent it has deemed necessary, (b) has conducted its own
due diligence on the Company, its subsidiaries and the Transaction, and (c)
has made its own investment decisions based upon its own judgment, due
diligence and advice from such advisers as it has deemed necessary.
4. The Investor has such knowledge and experience in financial, business and
international investment matters that it is capable of evaluating the
merits and risks of purchasing the Shares, and has had the opportunity to
ask questions of, and receive answers and request additional information
from the Company.
5. The Investor has the ability to bear the economic risk of the Transaction,
has adequate means of providing for its current and contingent needs, has
no need for liquidity with respect to its investment in the Shares, and is
able to sustain a complete loss in connection with the Transaction.
6. The Investor acknowledges, represents and agrees:
(i) that it is an accredited investor ("AI") as defined in Rule 501(a) of
the Securities Act, purchasing the Shares for its own account or for
the account of one or more AIs as defined in Rule 501(a) of the
Securities Act;
(ii) that it is aware, and each beneficial owner of the Shares has been
advised, that any sale to it is being made in reliance on an exemption
from the registration requirements of the Securities Act;
(iii) that no securities issuable upon conversion of the Shares (the
"CONVERSION SHARES") have been registered under the Securities Act or
any applicable U.S. state securities laws, that the Shares and the
Conversion Shares are "restricted securities" within the meaning of
Rule 144(a)(3) under the Securities Act and that no Shares or
Conversion Shares may be offered or sold within the United States or
to, or for the account or benefit of, U.S. persons (as defined in
Regulation S of the Securities Act) except as set forth in (iv) below;
(iv) if in the future it decides to resell, pledge or otherwise transfer
the Shares or the Conversion Shares or any beneficial interests
therein, it will do so, only (a) inside the United States to a person
whom the Investor reasonably believes is a QIB
pursuant to an exemption from registration under the Securities Act,
(b) outside the United States to a person other than a U.S. person (as
defined in Regulation S of the Securities Act) in compliance with
Regulation S of the Securities Act, (c) pursuant to another exemption
from registration under the Securities Act (if available) or (d)
pursuant to an effective registration statement under the Securities
Act, in each case, in accordance with the Securities Act and
applicable laws of the states, territories and possession of the
Untied States governing the offer and sale of securities;
(v) it will, and will require each subsequent holder of the Shares or the
Conversion Shares to, notify any purchaser of an interest in the
Shares or the Conversion Shares of the resale restrictions referred to
in paragraphs (iii) and (iv) above, if then applicable;
(vi) that the Conversion Shares will bear a legend setting forth the resale
restrictions referred to in paragraphs (iii) and (iv) above; and
(vii) on each day from the date on which it acquires the Shares, through
and including the date on which it disposes of its interests in such
Shares, either that (a) it is not an "employee benefit plan" as
defined in Section 3(3) of ERISA, subject to Title I of ERISA, a
"plan" (defined in Section 4975(e)(1) of the Code, subject to Section
4975 of the Code (including without limitation, an individual
retirement account), an entity whose underlying assets include the
assets of any such employee benefit plan or plan by reason of
Department of Labor Regulation section 2510.3-10 or otherwise, or a
governmental or church plan which is subject to any federal, state or
local law that is substantially similar to the provisions of Section
406 of ERISA or Section 4975 of the Code or (b) its purchase, holding
and disposition of such Notes will not result in a prohibited
transaction under Section 406 of ERISA or Section 4975 of the Code
(or, in the case of a governmental or church plan, any substantially
similar federal, state or local law) unless an exemption is available
with respect to such transactions and all the conditions of such
exemption have been satisfied.
7. The Investor understands that no action has been taken to permit an
offering of the Shares or the Conversion Shares in any jurisdiction; the
Investor will not offer or sell any of the Shares or the Conversion Shares
which may be acquired by it in any jurisdiction or in any circumstances in
which such offer or sale is not authorised or to any person to whom it is
unlawful to make such offer, sale or invitation except under circumstances
that will result in compliance with any applicable laws and/or regulations.
8. The Investor's purchase of the Shares is lawful under the securities laws
of the jurisdiction in which it accepts the offer to purchase the Shares.